id
stringlengths
14
28
title
stringclasses
18 values
content
stringlengths
2
999
contents
stringlengths
19
1.02k
Biochemistry_Lippincott_283
Biochemistry_Lippinco
A. Isomers and epimers Compounds that have the same chemical formula but have different structures are called isomers. For example, fructose, glucose, mannose, and galactose are all isomers of each other, having the same chemical formula, C6H12O6. Carbohydrate isomers that differ in configuration around only one specific carbon atom (with the exception of the carbonyl carbon, see C. 1. below) are defined as epimers of each other. For example, glucose and galactose are C-4 epimers because their structures differ only in the position of the –OH (hydroxyl) group at carbon 4. [Note: The carbons in sugars are numbered beginning at the end that contains the carbonyl carbon (that is, the aldehyde or keto group), as shown in Fig. 7.4.] Glucose and mannose are C-2 epimers. However, because galactose and mannose differ in the position of –OH groups at two carbons (carbons 2 and 4), they are isomers rather than epimers (see Fig. 7.4). B. Enantiomers
Biochemistry_Lippinco. A. Isomers and epimers Compounds that have the same chemical formula but have different structures are called isomers. For example, fructose, glucose, mannose, and galactose are all isomers of each other, having the same chemical formula, C6H12O6. Carbohydrate isomers that differ in configuration around only one specific carbon atom (with the exception of the carbonyl carbon, see C. 1. below) are defined as epimers of each other. For example, glucose and galactose are C-4 epimers because their structures differ only in the position of the –OH (hydroxyl) group at carbon 4. [Note: The carbons in sugars are numbered beginning at the end that contains the carbonyl carbon (that is, the aldehyde or keto group), as shown in Fig. 7.4.] Glucose and mannose are C-2 epimers. However, because galactose and mannose differ in the position of –OH groups at two carbons (carbons 2 and 4), they are isomers rather than epimers (see Fig. 7.4). B. Enantiomers
Biochemistry_Lippincott_284
Biochemistry_Lippinco
B. Enantiomers A special type of isomerism is found in the pairs of structures that are mirror images of each other. These mirror images are called enantiomers, and the two members of the pair are designated as a D-and an L-sugar (Fig. 7.5). The vast majority of the sugars in humans are D-isomers. In the D-isomeric form, the –OH group on the asymmetric carbon (a carbon linked to four different atoms or groups) farthest from the carbonyl carbon is on the right, whereas in the L-isomer, it is on the left. Most enzymes are specific for either the D or the L form, but enzymes known as isomerases are able to interconvert D-and L-isomers. comparison to a triose, glyceraldehyde. [Note: The asymmetric carbons are shown in green.] C. Monosaccharide cyclization
Biochemistry_Lippinco. B. Enantiomers A special type of isomerism is found in the pairs of structures that are mirror images of each other. These mirror images are called enantiomers, and the two members of the pair are designated as a D-and an L-sugar (Fig. 7.5). The vast majority of the sugars in humans are D-isomers. In the D-isomeric form, the –OH group on the asymmetric carbon (a carbon linked to four different atoms or groups) farthest from the carbonyl carbon is on the right, whereas in the L-isomer, it is on the left. Most enzymes are specific for either the D or the L form, but enzymes known as isomerases are able to interconvert D-and L-isomers. comparison to a triose, glyceraldehyde. [Note: The asymmetric carbons are shown in green.] C. Monosaccharide cyclization
Biochemistry_Lippincott_285
Biochemistry_Lippinco
comparison to a triose, glyceraldehyde. [Note: The asymmetric carbons are shown in green.] C. Monosaccharide cyclization Less than 1% of each of the monosaccharides with five or more carbons exists in the open-chain (acyclic) form in solution. Rather, they are predominantly found in a ring (cyclic) form, in which the aldehyde (or keto) group has reacted with a hydroxyl group on the same sugar, making the carbonyl carbon (carbon 1 for an aldose, carbon 2 for a ketose) asymmetric. This asymmetric carbon is referred to as the anomeric carbon.
Biochemistry_Lippinco. comparison to a triose, glyceraldehyde. [Note: The asymmetric carbons are shown in green.] C. Monosaccharide cyclization Less than 1% of each of the monosaccharides with five or more carbons exists in the open-chain (acyclic) form in solution. Rather, they are predominantly found in a ring (cyclic) form, in which the aldehyde (or keto) group has reacted with a hydroxyl group on the same sugar, making the carbonyl carbon (carbon 1 for an aldose, carbon 2 for a ketose) asymmetric. This asymmetric carbon is referred to as the anomeric carbon.
Biochemistry_Lippincott_286
Biochemistry_Lippinco
1. Anomers: Creation of an anomeric carbon (the former carbonyl carbon) generates a new pair of isomers, the α and β configurations of the sugar (for example, α-D-glucopyranose and β-D-glucopyranose), as shown in Figure 7.6, that are anomers of each other. [Note: In the α configuration, the –OH group on the anomeric carbon projects to the same side as the ring in a modified Fischer projection formula (see Fig. 7.6A) and is trans to the CH2OH group in a Haworth projection formula (see Fig. 7.6B).
Biochemistry_Lippinco. 1. Anomers: Creation of an anomeric carbon (the former carbonyl carbon) generates a new pair of isomers, the α and β configurations of the sugar (for example, α-D-glucopyranose and β-D-glucopyranose), as shown in Figure 7.6, that are anomers of each other. [Note: In the α configuration, the –OH group on the anomeric carbon projects to the same side as the ring in a modified Fischer projection formula (see Fig. 7.6A) and is trans to the CH2OH group in a Haworth projection formula (see Fig. 7.6B).
Biochemistry_Lippincott_287
Biochemistry_Lippinco
The α and β forms are not mirror images, and they are referred to as diastereomers.] Enzymes are able to distinguish between these two structures and use one or the other preferentially. For example, glycogen is synthesized from α-D-glucopyranose, whereas cellulose is synthesized from β-D-glucopyranose. The cyclic α and β anomers of a sugar in solution spontaneously (but slowly) form an equilibrium mixture, a process known as mutarotation (see Fig. 7.6). [Note: For glucose, the α form makes up 36% of the mixture.] six-membered ring (5 C + 1 O) is termed a pyranose, whereas one with a five-membered ring (4 C + 1 O) is a furanose. Virtually all glucose in solution is in the pyranose form.] 2. Reducing sugars: If the hydroxyl group on the anomeric carbon of a cyclized sugar is not linked to another compound by a glycosidic bond (see E. below), the ring can open. The sugar can act as a reducing agent and is termed a reducing sugar. Such sugars can react with chromogenic agents (for
Biochemistry_Lippinco. The α and β forms are not mirror images, and they are referred to as diastereomers.] Enzymes are able to distinguish between these two structures and use one or the other preferentially. For example, glycogen is synthesized from α-D-glucopyranose, whereas cellulose is synthesized from β-D-glucopyranose. The cyclic α and β anomers of a sugar in solution spontaneously (but slowly) form an equilibrium mixture, a process known as mutarotation (see Fig. 7.6). [Note: For glucose, the α form makes up 36% of the mixture.] six-membered ring (5 C + 1 O) is termed a pyranose, whereas one with a five-membered ring (4 C + 1 O) is a furanose. Virtually all glucose in solution is in the pyranose form.] 2. Reducing sugars: If the hydroxyl group on the anomeric carbon of a cyclized sugar is not linked to another compound by a glycosidic bond (see E. below), the ring can open. The sugar can act as a reducing agent and is termed a reducing sugar. Such sugars can react with chromogenic agents (for
Biochemistry_Lippincott_288
Biochemistry_Lippinco
to another compound by a glycosidic bond (see E. below), the ring can open. The sugar can act as a reducing agent and is termed a reducing sugar. Such sugars can react with chromogenic agents (for example, the Benedict reagent) causing the reagent to be reduced and colored as the aldehyde group of the acyclic sugar is oxidized to a carboxyl group. All monosaccharides, but not all disaccharides, are reducing sugars. [Note: Fructose, a ketose, is a reducing sugar because it can be isomerized to an aldose.]
Biochemistry_Lippinco. to another compound by a glycosidic bond (see E. below), the ring can open. The sugar can act as a reducing agent and is termed a reducing sugar. Such sugars can react with chromogenic agents (for example, the Benedict reagent) causing the reagent to be reduced and colored as the aldehyde group of the acyclic sugar is oxidized to a carboxyl group. All monosaccharides, but not all disaccharides, are reducing sugars. [Note: Fructose, a ketose, is a reducing sugar because it can be isomerized to an aldose.]
Biochemistry_Lippincott_289
Biochemistry_Lippinco
A colorimetric test can detect a reducing sugar in urine. A positive result is indicative of an underlying pathology (because sugars are not normally present in urine) and can be followed up by more specific tests to identify the reducing sugar. D. Monosaccharide joining Monosaccharides can be joined to form disaccharides, oligosaccharides, and polysaccharides. Important disaccharides include lactose (galactose + glucose), sucrose (glucose + fructose), and maltose (glucose + glucose). Important polysaccharides include branched glycogen (from animal sources) and starch (plant sources) and unbranched cellulose (plant sources). Each is a polymer of glucose. E. Glycosidic bonds
Biochemistry_Lippinco. A colorimetric test can detect a reducing sugar in urine. A positive result is indicative of an underlying pathology (because sugars are not normally present in urine) and can be followed up by more specific tests to identify the reducing sugar. D. Monosaccharide joining Monosaccharides can be joined to form disaccharides, oligosaccharides, and polysaccharides. Important disaccharides include lactose (galactose + glucose), sucrose (glucose + fructose), and maltose (glucose + glucose). Important polysaccharides include branched glycogen (from animal sources) and starch (plant sources) and unbranched cellulose (plant sources). Each is a polymer of glucose. E. Glycosidic bonds
Biochemistry_Lippincott_290
Biochemistry_Lippinco
E. Glycosidic bonds The bonds that link sugars are called glycosidic bonds. They are formed by enzymes known as glycosyltransferases that use nucleotide sugars (activated sugars) such as uridine diphosphate glucose as substrates. Glycosidic bonds between sugars are named according to the numbers of the connected carbons and with regard to the position of the anomeric hydroxyl group of the first sugar involved in the bond. If this anomeric hydroxyl is in the α configuration, then the linkage is an α-bond. If it is in the β configuration, then the linkage is a β-bond. Lactose, for example, is synthesized by forming a glycosidic bond between carbon 1 of β-galactose and carbon 4 of glucose. Therefore, the linkage is a β(1→4) glycosidic bond (see Fig. 7.3). [Note: Because the anomeric end of the glucose residue is not involved in the glycosidic linkage, it (and, therefore, lactose) remains a reducing sugar.] F. Carbohydrate linkage to noncarbohydrates
Biochemistry_Lippinco. E. Glycosidic bonds The bonds that link sugars are called glycosidic bonds. They are formed by enzymes known as glycosyltransferases that use nucleotide sugars (activated sugars) such as uridine diphosphate glucose as substrates. Glycosidic bonds between sugars are named according to the numbers of the connected carbons and with regard to the position of the anomeric hydroxyl group of the first sugar involved in the bond. If this anomeric hydroxyl is in the α configuration, then the linkage is an α-bond. If it is in the β configuration, then the linkage is a β-bond. Lactose, for example, is synthesized by forming a glycosidic bond between carbon 1 of β-galactose and carbon 4 of glucose. Therefore, the linkage is a β(1→4) glycosidic bond (see Fig. 7.3). [Note: Because the anomeric end of the glucose residue is not involved in the glycosidic linkage, it (and, therefore, lactose) remains a reducing sugar.] F. Carbohydrate linkage to noncarbohydrates
Biochemistry_Lippincott_291
Biochemistry_Lippinco
F. Carbohydrate linkage to noncarbohydrates Carbohydrates can be attached by glycosidic bonds to noncarbohydrate structures, including purine and pyrimidine bases (found in nucleic acids), aromatic rings (such as those found in steroids and bilirubin), proteins (found in glycoproteins and proteoglycans), and lipids (found in glycolipids). If the group on the noncarbohydrate molecule to which the sugar is attached is an –NH2 group, then the bond is called an N-glycosidic link. If the group is an –OH, then the bond is an O-glycosidic link (Fig. 7.7). [Note: All sugar-sugar glycosidic bonds are O-type linkages.] III. DIETARY CARBOHYDRATE DIGESTION
Biochemistry_Lippinco. F. Carbohydrate linkage to noncarbohydrates Carbohydrates can be attached by glycosidic bonds to noncarbohydrate structures, including purine and pyrimidine bases (found in nucleic acids), aromatic rings (such as those found in steroids and bilirubin), proteins (found in glycoproteins and proteoglycans), and lipids (found in glycolipids). If the group on the noncarbohydrate molecule to which the sugar is attached is an –NH2 group, then the bond is called an N-glycosidic link. If the group is an –OH, then the bond is an O-glycosidic link (Fig. 7.7). [Note: All sugar-sugar glycosidic bonds are O-type linkages.] III. DIETARY CARBOHYDRATE DIGESTION
Biochemistry_Lippincott_292
Biochemistry_Lippinco
III. DIETARY CARBOHYDRATE DIGESTION The principal sites of dietary carbohydrate digestion are the mouth and intestinal lumen. This digestion is rapid and is catalyzed by enzymes known as glycoside hydrolases (glycosidases) that hydrolyze glycosidic bonds (Fig. 7.8). Because little monosaccharide is present in diets of mixed animal and plant origin, the enzymes are primarily endoglycosidases that hydrolyze polysaccharides and oligosaccharides and disaccharidases that hydrolyze tri-and disaccharides into their reducing sugar components. Glycosidases are usually specific for the structure and configuration of the glycosyl residue to be removed as well as for the type of bond to be broken. The final products of carbohydrate digestion are the monosaccharides glucose, galactose, and fructose that are absorbed by cells (enterocytes) of the small intestine. A. Salivary α-amylase
Biochemistry_Lippinco. III. DIETARY CARBOHYDRATE DIGESTION The principal sites of dietary carbohydrate digestion are the mouth and intestinal lumen. This digestion is rapid and is catalyzed by enzymes known as glycoside hydrolases (glycosidases) that hydrolyze glycosidic bonds (Fig. 7.8). Because little monosaccharide is present in diets of mixed animal and plant origin, the enzymes are primarily endoglycosidases that hydrolyze polysaccharides and oligosaccharides and disaccharidases that hydrolyze tri-and disaccharides into their reducing sugar components. Glycosidases are usually specific for the structure and configuration of the glycosyl residue to be removed as well as for the type of bond to be broken. The final products of carbohydrate digestion are the monosaccharides glucose, galactose, and fructose that are absorbed by cells (enterocytes) of the small intestine. A. Salivary α-amylase
Biochemistry_Lippincott_293
Biochemistry_Lippinco
A. Salivary α-amylase The major dietary polysaccharides are of plant (starch, composed of amylose and amylopectin) and animal (glycogen) origin. During mastication (chewing), salivary α-amylase acts briefly on dietary starch and glycogen, hydrolyzing random α(1→4) bonds. [Note: There are both α(1→4)-and β(1→4)-endoglucosidases in nature, but humans do not produce the latter. Therefore, we are unable to digest cellulose, a carbohydrate of plant origin containing β(1→4) glycosidic bonds between glucose residues.] Because branched amylopectin and glycogen also contain α(1→6) bonds, which α-amylase cannot hydrolyze, the digest resulting from its action contains a mixture of short, branched and unbranched oligosaccharides known as dextrins (Fig. 7.9). [Note: Disaccharides are also present as they, too, are resistant to amylase.] Carbohydrate digestion halts temporarily in the stomach, because the high acidity inactivates salivary α-amylase. B. Pancreatic α-amylase
Biochemistry_Lippinco. A. Salivary α-amylase The major dietary polysaccharides are of plant (starch, composed of amylose and amylopectin) and animal (glycogen) origin. During mastication (chewing), salivary α-amylase acts briefly on dietary starch and glycogen, hydrolyzing random α(1→4) bonds. [Note: There are both α(1→4)-and β(1→4)-endoglucosidases in nature, but humans do not produce the latter. Therefore, we are unable to digest cellulose, a carbohydrate of plant origin containing β(1→4) glycosidic bonds between glucose residues.] Because branched amylopectin and glycogen also contain α(1→6) bonds, which α-amylase cannot hydrolyze, the digest resulting from its action contains a mixture of short, branched and unbranched oligosaccharides known as dextrins (Fig. 7.9). [Note: Disaccharides are also present as they, too, are resistant to amylase.] Carbohydrate digestion halts temporarily in the stomach, because the high acidity inactivates salivary α-amylase. B. Pancreatic α-amylase
Biochemistry_Lippincott_294
Biochemistry_Lippinco
Carbohydrate digestion halts temporarily in the stomach, because the high acidity inactivates salivary α-amylase. B. Pancreatic α-amylase When the acidic stomach contents reach the small intestine, they are neutralized by bicarbonate secreted by the pancreas, and pancreatic αamylase continues the process of starch digestion. C. Intestinal disaccharidases
Biochemistry_Lippinco. Carbohydrate digestion halts temporarily in the stomach, because the high acidity inactivates salivary α-amylase. B. Pancreatic α-amylase When the acidic stomach contents reach the small intestine, they are neutralized by bicarbonate secreted by the pancreas, and pancreatic αamylase continues the process of starch digestion. C. Intestinal disaccharidases
Biochemistry_Lippincott_295
Biochemistry_Lippinco
C. Intestinal disaccharidases The final digestive processes occur primarily at the mucosal lining of the duodenum and upper jejunum and include the action of several disaccharidases (see Fig. 7.9). For example, isomaltase cleaves the α(1→6) bond in isomaltose, and maltase cleaves the α(1→4) bond in maltose and maltotriose, each producing glucose. Sucrase cleaves the α(1→2) bond in sucrose, producing glucose and fructose, and lactase (β-galactosidase) cleaves the β(1→4) bond in lactose, producing galactose and glucose. [Note: The substrates for isomaltase are broader than its name suggests, and it hydrolyzes the majority of maltose.] Trehalose, an α(1→1) disaccharide of glucose found in mushrooms and other fungi, is cleaved by trehalase. These enzymes are transmembrane proteins of the brush border on the luminal (apical) surface of the enterocytes.
Biochemistry_Lippinco. C. Intestinal disaccharidases The final digestive processes occur primarily at the mucosal lining of the duodenum and upper jejunum and include the action of several disaccharidases (see Fig. 7.9). For example, isomaltase cleaves the α(1→6) bond in isomaltose, and maltase cleaves the α(1→4) bond in maltose and maltotriose, each producing glucose. Sucrase cleaves the α(1→2) bond in sucrose, producing glucose and fructose, and lactase (β-galactosidase) cleaves the β(1→4) bond in lactose, producing galactose and glucose. [Note: The substrates for isomaltase are broader than its name suggests, and it hydrolyzes the majority of maltose.] Trehalose, an α(1→1) disaccharide of glucose found in mushrooms and other fungi, is cleaved by trehalase. These enzymes are transmembrane proteins of the brush border on the luminal (apical) surface of the enterocytes.
Biochemistry_Lippincott_296
Biochemistry_Lippinco
Sucrase and isomaltase are enzymic activities of a single protein that is cleaved into two functional subunits, which remain associated in the cell membrane and form the sucrase-isomaltase (SI) complex. In contrast, maltase is one of two enzymic activities of the single membrane protein maltase-glucoamylase (MGA) that does not get cleaved. Its second enzymic activity, glucoamylase, cleaves α(1→4) glycosidic bonds in dextrins. D. Intestinal absorption of monosaccharides
Biochemistry_Lippinco. Sucrase and isomaltase are enzymic activities of a single protein that is cleaved into two functional subunits, which remain associated in the cell membrane and form the sucrase-isomaltase (SI) complex. In contrast, maltase is one of two enzymic activities of the single membrane protein maltase-glucoamylase (MGA) that does not get cleaved. Its second enzymic activity, glucoamylase, cleaves α(1→4) glycosidic bonds in dextrins. D. Intestinal absorption of monosaccharides
Biochemistry_Lippincott_297
Biochemistry_Lippinco
D. Intestinal absorption of monosaccharides The upper jejunum absorbs the bulk of the monosaccharide products of digestion. However, different sugars have different mechanisms of absorption (Fig. 7.10). For example, galactose and glucose are taken into enterocytes by secondary active transport that requires a concurrent uptake (symport) of sodium (Na+) ions. The transport protein is the sodium-dependent glucose cotransporter 1 (SGLT-1). [Note: Sugar transport is driven by the Na+ gradient created by the Na+-potassium (K+) ATPase that moves Na+ out of the enterocyte and K+ in (see Fig. 7.10).] Fructose absorption utilizes an energy-and Na+-independent monosaccharide transporter (GLUT-5). All three monosaccharides are transported from the enterocytes into the portal circulation by yet another transporter, GLUT-2. [Note: See p. 97 for a discussion of these transporters.] E. Abnormal degradation of disaccharides
Biochemistry_Lippinco. D. Intestinal absorption of monosaccharides The upper jejunum absorbs the bulk of the monosaccharide products of digestion. However, different sugars have different mechanisms of absorption (Fig. 7.10). For example, galactose and glucose are taken into enterocytes by secondary active transport that requires a concurrent uptake (symport) of sodium (Na+) ions. The transport protein is the sodium-dependent glucose cotransporter 1 (SGLT-1). [Note: Sugar transport is driven by the Na+ gradient created by the Na+-potassium (K+) ATPase that moves Na+ out of the enterocyte and K+ in (see Fig. 7.10).] Fructose absorption utilizes an energy-and Na+-independent monosaccharide transporter (GLUT-5). All three monosaccharides are transported from the enterocytes into the portal circulation by yet another transporter, GLUT-2. [Note: See p. 97 for a discussion of these transporters.] E. Abnormal degradation of disaccharides
Biochemistry_Lippincott_298
Biochemistry_Lippinco
E. Abnormal degradation of disaccharides The overall process of carbohydrate digestion and absorption is so efficient in healthy individuals that ordinarily all digestible dietary carbohydrate is absorbed by the time the ingested material reaches the lower jejunum. However, because only monosaccharides are absorbed, any deficiency (genetic or acquired) in a specific disaccharidase activity of the intestinal mucosa causes the passage of undigested carbohydrate into the large intestine. As a consequence of the presence of this osmotically active material, water is drawn from the mucosa into the large intestine, causing osmotic diarrhea. This is reinforced by the bacterial fermentation of the remaining carbohydrate to two-and three-carbon compounds (which are also osmotically active) plus large volumes of carbon dioxide and hydrogen gas (H2), causing abdominal cramps, diarrhea, and flatulence. 1.
Biochemistry_Lippinco. E. Abnormal degradation of disaccharides The overall process of carbohydrate digestion and absorption is so efficient in healthy individuals that ordinarily all digestible dietary carbohydrate is absorbed by the time the ingested material reaches the lower jejunum. However, because only monosaccharides are absorbed, any deficiency (genetic or acquired) in a specific disaccharidase activity of the intestinal mucosa causes the passage of undigested carbohydrate into the large intestine. As a consequence of the presence of this osmotically active material, water is drawn from the mucosa into the large intestine, causing osmotic diarrhea. This is reinforced by the bacterial fermentation of the remaining carbohydrate to two-and three-carbon compounds (which are also osmotically active) plus large volumes of carbon dioxide and hydrogen gas (H2), causing abdominal cramps, diarrhea, and flatulence. 1.
Biochemistry_Lippincott_299
Biochemistry_Lippinco
1. Digestive enzyme deficiencies: Genetic deficiencies of the individual disaccharidases result in disaccharide intolerance. Alterations in disaccharide degradation can also be caused by a variety of intestinal diseases, malnutrition, and drugs that injure the mucosa of the small intestine. For example, brush border enzymes are rapidly lost in normal individuals with severe diarrhea, causing a temporary, acquired enzyme deficiency. Therefore, patients suffering or recovering from such a disorder cannot drink or eat significant amounts of dairy products or sucrose without exacerbating the diarrhea. 2.
Biochemistry_Lippinco. 1. Digestive enzyme deficiencies: Genetic deficiencies of the individual disaccharidases result in disaccharide intolerance. Alterations in disaccharide degradation can also be caused by a variety of intestinal diseases, malnutrition, and drugs that injure the mucosa of the small intestine. For example, brush border enzymes are rapidly lost in normal individuals with severe diarrhea, causing a temporary, acquired enzyme deficiency. Therefore, patients suffering or recovering from such a disorder cannot drink or eat significant amounts of dairy products or sucrose without exacerbating the diarrhea. 2.
Biochemistry_Lippincott_300
Biochemistry_Lippinco
Lactose intolerance: Over 60% of the world’s adults are lactose intolerant (Fig. 7.11). This is particularly manifested in certain populations. For example, up to 90% of adults of African or Asian descent are lactase deficient. Consequently, they are less able to metabolize lactose than are individuals of Northern European origin. The age-dependent loss of lactase activity starting at approximately age 2 years represents a reduction in the amount of enzyme produced. It is thought to be caused by small variations in the DNA sequence of a region on chromosome 2 that controls expression of the gene for lactase, also on chromosome 2. Treatment for this disorder is to reduce consumption of milk; eat yogurts and some cheeses (bacterial action and aging process decrease lactose content) as well as green vegetables, such as broccoli, to ensure adequate calcium intake; use lactase-treated products; or take lactase in pill form prior to eating. [Note: Because the loss of lactase is the norm for
Biochemistry_Lippinco. Lactose intolerance: Over 60% of the world’s adults are lactose intolerant (Fig. 7.11). This is particularly manifested in certain populations. For example, up to 90% of adults of African or Asian descent are lactase deficient. Consequently, they are less able to metabolize lactose than are individuals of Northern European origin. The age-dependent loss of lactase activity starting at approximately age 2 years represents a reduction in the amount of enzyme produced. It is thought to be caused by small variations in the DNA sequence of a region on chromosome 2 that controls expression of the gene for lactase, also on chromosome 2. Treatment for this disorder is to reduce consumption of milk; eat yogurts and some cheeses (bacterial action and aging process decrease lactose content) as well as green vegetables, such as broccoli, to ensure adequate calcium intake; use lactase-treated products; or take lactase in pill form prior to eating. [Note: Because the loss of lactase is the norm for
Biochemistry_Lippincott_301
Biochemistry_Lippinco
green vegetables, such as broccoli, to ensure adequate calcium intake; use lactase-treated products; or take lactase in pill form prior to eating. [Note: Because the loss of lactase is the norm for most of the world’s adults, use of the terms adult-type hypolactasia or lactase nonpersistence rather than lactose intolerance is becoming more common.] Rare cases of congenital lactase deficiency are known.
Biochemistry_Lippinco. green vegetables, such as broccoli, to ensure adequate calcium intake; use lactase-treated products; or take lactase in pill form prior to eating. [Note: Because the loss of lactase is the norm for most of the world’s adults, use of the terms adult-type hypolactasia or lactase nonpersistence rather than lactose intolerance is becoming more common.] Rare cases of congenital lactase deficiency are known.
Biochemistry_Lippincott_302
Biochemistry_Lippinco
3. Congenital sucrase-isomaltase deficiency: This autosomal-recessive disorder results in an intolerance of ingested sucrose. Congenital SI deficiency has a prevalence of 1:5,000 in individuals of European descent and appears to be much more common (up to 1:20) in the Inuit people of Greenland and Canada. Treatment includes the dietary restriction of sucrose and enzyme replacement therapy. 4. Diagnosis: Identification of a specific enzyme deficiency can be obtained by performing oral tolerance tests with the individual disaccharides. Measurement of H2 in the breath is a reliable test for determining the amount of ingested carbohydrate not absorbed by the body, but which is metabolized instead by the intestinal flora (see Fig. 7.11). IV. CHAPTER SUMMARY
Biochemistry_Lippinco. 3. Congenital sucrase-isomaltase deficiency: This autosomal-recessive disorder results in an intolerance of ingested sucrose. Congenital SI deficiency has a prevalence of 1:5,000 in individuals of European descent and appears to be much more common (up to 1:20) in the Inuit people of Greenland and Canada. Treatment includes the dietary restriction of sucrose and enzyme replacement therapy. 4. Diagnosis: Identification of a specific enzyme deficiency can be obtained by performing oral tolerance tests with the individual disaccharides. Measurement of H2 in the breath is a reliable test for determining the amount of ingested carbohydrate not absorbed by the body, but which is metabolized instead by the intestinal flora (see Fig. 7.11). IV. CHAPTER SUMMARY
Biochemistry_Lippincott_303
Biochemistry_Lippinco
IV. CHAPTER SUMMARY Monosaccharides (Fig. 7.12) containing an aldehyde group are called aldoses, and those with a keto group are called ketoses. Disaccharides, oligosaccharides, and polysaccharides consist of monosaccharides linked by glycosidic bonds. Compounds with the same chemical formula but different structures are called isomers. Two monosaccharide isomers differing in configuration around one specific carbon atom (not the carbonyl carbon) are defined as epimers. In enantiomers (mirror images), the members of the sugar pair are designated as D-and L-isomers. When the aldehyde group on an acyclic sugar gets oxidized as a chromogenic agent gets reduced, that sugar is a reducing sugar. When a sugar cyclizes, an anomeric carbon is created from the carbonyl carbon of the aldehyde or keto group. The sugar can have two configurations, forming α or β anomers. A sugar can have its anomeric carbon linked to an –NH2 or an –
Biochemistry_Lippinco. IV. CHAPTER SUMMARY Monosaccharides (Fig. 7.12) containing an aldehyde group are called aldoses, and those with a keto group are called ketoses. Disaccharides, oligosaccharides, and polysaccharides consist of monosaccharides linked by glycosidic bonds. Compounds with the same chemical formula but different structures are called isomers. Two monosaccharide isomers differing in configuration around one specific carbon atom (not the carbonyl carbon) are defined as epimers. In enantiomers (mirror images), the members of the sugar pair are designated as D-and L-isomers. When the aldehyde group on an acyclic sugar gets oxidized as a chromogenic agent gets reduced, that sugar is a reducing sugar. When a sugar cyclizes, an anomeric carbon is created from the carbonyl carbon of the aldehyde or keto group. The sugar can have two configurations, forming α or β anomers. A sugar can have its anomeric carbon linked to an –NH2 or an –
Biochemistry_Lippincott_304
Biochemistry_Lippinco
OH group on another structure through N-and O-glycosidic bonds, respectively. Salivary α-amylase initiates digestion of dietary polysaccharides (for example, starch or glycogen), producing oligosaccharides. Pancreatic α-amylase continues the process. The final digestive processes occur at the mucosal lining of the small intestine. Several disaccharidases (for example, lactase [β-galactosidase], sucrase, isomaltase, and maltase) produce monosaccharides (glucose, galactose, and fructose). These enzymes are transmembrane proteins of the luminal brush border of intestinal mucosal cells (enterocytes). Absorption of the monosaccharides requires specific transporters. If carbohydrate degradation is deficient (as a result of heredity, disease, or drugs that injure the intestinal mucosa), undigested carbohydrate will pass into the large intestine, where it can cause osmotic diarrhea. Bacterial fermentation of the material produces large volumes of carbon dioxide and hydrogen gas, causing
Biochemistry_Lippinco. OH group on another structure through N-and O-glycosidic bonds, respectively. Salivary α-amylase initiates digestion of dietary polysaccharides (for example, starch or glycogen), producing oligosaccharides. Pancreatic α-amylase continues the process. The final digestive processes occur at the mucosal lining of the small intestine. Several disaccharidases (for example, lactase [β-galactosidase], sucrase, isomaltase, and maltase) produce monosaccharides (glucose, galactose, and fructose). These enzymes are transmembrane proteins of the luminal brush border of intestinal mucosal cells (enterocytes). Absorption of the monosaccharides requires specific transporters. If carbohydrate degradation is deficient (as a result of heredity, disease, or drugs that injure the intestinal mucosa), undigested carbohydrate will pass into the large intestine, where it can cause osmotic diarrhea. Bacterial fermentation of the material produces large volumes of carbon dioxide and hydrogen gas, causing
Biochemistry_Lippincott_305
Biochemistry_Lippinco
carbohydrate will pass into the large intestine, where it can cause osmotic diarrhea. Bacterial fermentation of the material produces large volumes of carbon dioxide and hydrogen gas, causing abdominal cramps, diarrhea, and flatulence. Lactose intolerance, primarily caused by the age-dependent loss of lactase (adult-type hypolactasia), is by far the most common of these deficiencies.
Biochemistry_Lippinco. carbohydrate will pass into the large intestine, where it can cause osmotic diarrhea. Bacterial fermentation of the material produces large volumes of carbon dioxide and hydrogen gas, causing abdominal cramps, diarrhea, and flatulence. Lactose intolerance, primarily caused by the age-dependent loss of lactase (adult-type hypolactasia), is by far the most common of these deficiencies.
Biochemistry_Lippincott_306
Biochemistry_Lippinco
Choose the ONE best answer. .1. Which of the following statements best describes glucose? A. It is a C-4 epimer of galactose. B. It is a ketose and usually exists as a furanose ring in solution. C. It is produced from dietary starch by the action of α-amylase. D. It is utilized in biological systems only in the L-isomeric form. Correct answer = A. Because glucose and galactose differ only in configuration around carbon 4, they are C-4 epimers that are interconvertible by the action of an epimerase. Glucose is an aldose sugar that typically exists as a pyranose ring in solution. Fructose, however, is a ketose with a furanose ring. α-Amylase does not produce monosaccharides. The D-isomeric form of carbohydrates is the form typically found in biologic systems, in contrast to amino acids that typically are found in the L-isomeric form.
Biochemistry_Lippinco. Choose the ONE best answer. .1. Which of the following statements best describes glucose? A. It is a C-4 epimer of galactose. B. It is a ketose and usually exists as a furanose ring in solution. C. It is produced from dietary starch by the action of α-amylase. D. It is utilized in biological systems only in the L-isomeric form. Correct answer = A. Because glucose and galactose differ only in configuration around carbon 4, they are C-4 epimers that are interconvertible by the action of an epimerase. Glucose is an aldose sugar that typically exists as a pyranose ring in solution. Fructose, however, is a ketose with a furanose ring. α-Amylase does not produce monosaccharides. The D-isomeric form of carbohydrates is the form typically found in biologic systems, in contrast to amino acids that typically are found in the L-isomeric form.
Biochemistry_Lippincott_307
Biochemistry_Lippinco
.2. A young man entered his physician’s office complaining of bloating and diarrhea. His eyes were sunken, and the physician noted additional signs of dehydration. The patient’s temperature was normal. He explained that the episode had occurred following a birthday party at which he had participated in an ice cream–eating contest. The patient reported prior episodes of a similar nature following ingestion of a significant amount of dairy products. This clinical picture is most probably due to a deficiency in the activity of: A. isomaltase. B. lactase. C. pancreatic α-amylase. D. salivary α-amylase. E. sucrase. Correct answer = B. The physical symptoms suggest a deficiency in an enzyme responsible for carbohydrate degradation. The symptoms observed following the ingestion of dairy products suggest that the patient is deficient in lactase as a result of the age-dependent reduction in expression of the enzyme.
Biochemistry_Lippinco. .2. A young man entered his physician’s office complaining of bloating and diarrhea. His eyes were sunken, and the physician noted additional signs of dehydration. The patient’s temperature was normal. He explained that the episode had occurred following a birthday party at which he had participated in an ice cream–eating contest. The patient reported prior episodes of a similar nature following ingestion of a significant amount of dairy products. This clinical picture is most probably due to a deficiency in the activity of: A. isomaltase. B. lactase. C. pancreatic α-amylase. D. salivary α-amylase. E. sucrase. Correct answer = B. The physical symptoms suggest a deficiency in an enzyme responsible for carbohydrate degradation. The symptoms observed following the ingestion of dairy products suggest that the patient is deficient in lactase as a result of the age-dependent reduction in expression of the enzyme.
Biochemistry_Lippincott_308
Biochemistry_Lippinco
.3. Routine examination of the urine of an asymptomatic pediatric patient showed a positive reaction with Clinitest (a copper reduction method of detecting reducing sugars) but a negative reaction with the glucose oxidase test for detecting glucose. Using these data, show on the chart below which of the sugars could (YES) or could not (NO) be present in the urine of this individual. Each of the listed sugars, except for sucrose and glucose, could be present in the urine of this individual. Clinitest is a nonspecific test that produces a change in color if urine is positive for reducing substances such as reducing sugars (fructose, galactose, glucose, lactose, xylulose). Because sucrose is not a reducing sugar, it is not detected by Clinitest. The glucose oxidase test will detect only glucose, and it cannot detect other sugars. The negative glucose oxidase test coupled with a positive reducing sugar test means that glucose cannot be the reducing sugar in the patient’s urine.
Biochemistry_Lippinco. .3. Routine examination of the urine of an asymptomatic pediatric patient showed a positive reaction with Clinitest (a copper reduction method of detecting reducing sugars) but a negative reaction with the glucose oxidase test for detecting glucose. Using these data, show on the chart below which of the sugars could (YES) or could not (NO) be present in the urine of this individual. Each of the listed sugars, except for sucrose and glucose, could be present in the urine of this individual. Clinitest is a nonspecific test that produces a change in color if urine is positive for reducing substances such as reducing sugars (fructose, galactose, glucose, lactose, xylulose). Because sucrose is not a reducing sugar, it is not detected by Clinitest. The glucose oxidase test will detect only glucose, and it cannot detect other sugars. The negative glucose oxidase test coupled with a positive reducing sugar test means that glucose cannot be the reducing sugar in the patient’s urine.
Biochemistry_Lippincott_309
Biochemistry_Lippinco
.4. Why are α-glucosidase inhibitors that are taken with meals, such as acarbose and miglitol, used in the treatment of diabetes? What effect should these drugs have on the digestion of lactose? α-Glucosidase inhibitors slow the production of glucose from dietary carbohydrates, thereby reducing the postprandial rise in blood glucose and facilitating better blood glucose control in diabetic patients. These drugs have no effect on lactose digestion because the disaccharide lactose contains a βglycosidic bond, not an α-glycosidic bond. Introduction to Metabolism and Glycolysis 8 For additional ancillary materials related to this chapter, please visit thePoint. I. METABOLISM OVERVIEW
Biochemistry_Lippinco. .4. Why are α-glucosidase inhibitors that are taken with meals, such as acarbose and miglitol, used in the treatment of diabetes? What effect should these drugs have on the digestion of lactose? α-Glucosidase inhibitors slow the production of glucose from dietary carbohydrates, thereby reducing the postprandial rise in blood glucose and facilitating better blood glucose control in diabetic patients. These drugs have no effect on lactose digestion because the disaccharide lactose contains a βglycosidic bond, not an α-glycosidic bond. Introduction to Metabolism and Glycolysis 8 For additional ancillary materials related to this chapter, please visit thePoint. I. METABOLISM OVERVIEW
Biochemistry_Lippincott_310
Biochemistry_Lippinco
In Chapter 5, individual enzymic reactions were analyzed in an effort to explain the mechanisms of catalysis. However, in cells, these reactions rarely occur in isolation. Instead, they are organized into multistep sequences called pathways, such as that of glycolysis (Fig. 8.1). In a pathway, the product of one reaction serves as the substrate of the subsequent reaction. Most pathways can be classified as either catabolic (degradative) or anabolic (synthetic). Catabolic pathways break down complex molecules, such as proteins, polysaccharides, and lipids, to a few simple molecules (for example, carbon dioxide, ammonia, and water). Anabolic pathways form complex end products from simple precursors, for example, the synthesis of the polysaccharide glycogen from glucose. [Note: Pathways that regenerate a component are called cycles.] Different pathways can intersect, forming an integrated and purposeful network of chemical reactions. Metabolism is the sum of all the chemical changes
Biochemistry_Lippinco. In Chapter 5, individual enzymic reactions were analyzed in an effort to explain the mechanisms of catalysis. However, in cells, these reactions rarely occur in isolation. Instead, they are organized into multistep sequences called pathways, such as that of glycolysis (Fig. 8.1). In a pathway, the product of one reaction serves as the substrate of the subsequent reaction. Most pathways can be classified as either catabolic (degradative) or anabolic (synthetic). Catabolic pathways break down complex molecules, such as proteins, polysaccharides, and lipids, to a few simple molecules (for example, carbon dioxide, ammonia, and water). Anabolic pathways form complex end products from simple precursors, for example, the synthesis of the polysaccharide glycogen from glucose. [Note: Pathways that regenerate a component are called cycles.] Different pathways can intersect, forming an integrated and purposeful network of chemical reactions. Metabolism is the sum of all the chemical changes
Biochemistry_Lippincott_311
Biochemistry_Lippinco
that regenerate a component are called cycles.] Different pathways can intersect, forming an integrated and purposeful network of chemical reactions. Metabolism is the sum of all the chemical changes occurring in a cell, a tissue, or the body. The next several chapters focus on the central metabolic pathways that are involved in synthesizing and degrading carbohydrates, lipids, and amino acids.
Biochemistry_Lippinco. that regenerate a component are called cycles.] Different pathways can intersect, forming an integrated and purposeful network of chemical reactions. Metabolism is the sum of all the chemical changes occurring in a cell, a tissue, or the body. The next several chapters focus on the central metabolic pathways that are involved in synthesizing and degrading carbohydrates, lipids, and amino acids.
Biochemistry_Lippincott_312
Biochemistry_Lippinco
A. Metabolic map Metabolism is best understood by examining its component pathways. Each pathway is composed of multienzyme sequences, and each enzyme, in turn, may exhibit important catalytic or regulatory features. A metabolic map containing the important central pathways of energy metabolism is presented in Figure 8.2. This “big picture” view of metabolism is useful in tracing connections between pathways, visualizing the purposeful movement of metabolic intermediates (metabolites), and depicting the effect on the flow of intermediates if a pathway is blocked (for example, by a drug or an inherited deficiency of an enzyme). [Note: The metabolome is the full complement of metabolites in an organism.] Throughout the next three units of this book, each pathway under discussion will be repeatedly featured as part of the major metabolic map shown in Figure 8.2. intermediates of protein metabolism. UDP = uridine diphosphate; P = phosphate; -
Biochemistry_Lippinco. A. Metabolic map Metabolism is best understood by examining its component pathways. Each pathway is composed of multienzyme sequences, and each enzyme, in turn, may exhibit important catalytic or regulatory features. A metabolic map containing the important central pathways of energy metabolism is presented in Figure 8.2. This “big picture” view of metabolism is useful in tracing connections between pathways, visualizing the purposeful movement of metabolic intermediates (metabolites), and depicting the effect on the flow of intermediates if a pathway is blocked (for example, by a drug or an inherited deficiency of an enzyme). [Note: The metabolome is the full complement of metabolites in an organism.] Throughout the next three units of this book, each pathway under discussion will be repeatedly featured as part of the major metabolic map shown in Figure 8.2. intermediates of protein metabolism. UDP = uridine diphosphate; P = phosphate; -
Biochemistry_Lippincott_313
Biochemistry_Lippinco
intermediates of protein metabolism. UDP = uridine diphosphate; P = phosphate; - CoA = coenzyme A; CO2 = carbon dioxide; HCO3 = bicarbonate; NH3 = ammonia. B. Catabolic pathways Catabolic reactions serve to capture chemical energy in the form of ATP from the degradation of energy-rich fuel molecules. ATP generation by degradation of complex molecules occurs in three stages, as shown in Figure 8.3. [Note: Catabolic pathways are typically oxidative and require oxidized coenzymes such as nicotinamide adenine dinucleotide (NAD+).] Catabolism also allows molecules in the diet (or nutrient molecules stored in cells) to be converted into basic building blocks needed for the synthesis of complex molecules. Catabolism, then, is a convergent process (that is, a wide variety of molecules are transformed into a few common end products). 1.
Biochemistry_Lippinco. intermediates of protein metabolism. UDP = uridine diphosphate; P = phosphate; - CoA = coenzyme A; CO2 = carbon dioxide; HCO3 = bicarbonate; NH3 = ammonia. B. Catabolic pathways Catabolic reactions serve to capture chemical energy in the form of ATP from the degradation of energy-rich fuel molecules. ATP generation by degradation of complex molecules occurs in three stages, as shown in Figure 8.3. [Note: Catabolic pathways are typically oxidative and require oxidized coenzymes such as nicotinamide adenine dinucleotide (NAD+).] Catabolism also allows molecules in the diet (or nutrient molecules stored in cells) to be converted into basic building blocks needed for the synthesis of complex molecules. Catabolism, then, is a convergent process (that is, a wide variety of molecules are transformed into a few common end products). 1.
Biochemistry_Lippincott_314
Biochemistry_Lippinco
1. Hydrolysis of complex molecules: In the first stage, complex molecules are broken down into their component building blocks. For example, proteins are degraded to amino acids, polysaccharides to monosaccharides, and fats (triacylglycerols) to free fatty acids and glycerol. 2. Conversion of building blocks to simple intermediates: In the second stage, these diverse building blocks are further degraded to acetyl coenzyme A (CoA) and a few other simple molecules. Some energy is captured as ATP, but the amount is small compared with the energy produced during the third stage of catabolism. 3. Oxidation of acetyl coenzyme A: The tricarboxylic acid (TCA) cycle (see p. 109) is the final common pathway in the oxidation of fuel molecules that produce acetyl CoA. Oxidation of acetyl CoA generates large amounts of ATP via oxidative phosphorylation as electrons flow from NADH and flavin adenine dinucleotide (FADH2) to oxygen ([O2] see p. 73). C. Anabolic pathways
Biochemistry_Lippinco. 1. Hydrolysis of complex molecules: In the first stage, complex molecules are broken down into their component building blocks. For example, proteins are degraded to amino acids, polysaccharides to monosaccharides, and fats (triacylglycerols) to free fatty acids and glycerol. 2. Conversion of building blocks to simple intermediates: In the second stage, these diverse building blocks are further degraded to acetyl coenzyme A (CoA) and a few other simple molecules. Some energy is captured as ATP, but the amount is small compared with the energy produced during the third stage of catabolism. 3. Oxidation of acetyl coenzyme A: The tricarboxylic acid (TCA) cycle (see p. 109) is the final common pathway in the oxidation of fuel molecules that produce acetyl CoA. Oxidation of acetyl CoA generates large amounts of ATP via oxidative phosphorylation as electrons flow from NADH and flavin adenine dinucleotide (FADH2) to oxygen ([O2] see p. 73). C. Anabolic pathways
Biochemistry_Lippincott_315
Biochemistry_Lippinco
73). C. Anabolic pathways In contrast to catabolism, anabolism is a divergent process in which a few biosynthetic precursors (such as amino acids) form a wide variety of polymeric, or complex, products (such as proteins [Fig. 8.4]). Anabolic reactions require energy (are endergonic), which is generally provided by the hydrolysis of ATP to adenosine diphosphate (ADP) and inorganic phosphate (Pi). [Note: Catabolic reactions generate energy (are exergonic).] Anabolic reactions often involve chemical reductions in which the reducing power is most frequently provided by the electron donor NADPH (phosphorylated NADH, see p. 147). II. METABOLISM REGULATION
Biochemistry_Lippinco. 73). C. Anabolic pathways In contrast to catabolism, anabolism is a divergent process in which a few biosynthetic precursors (such as amino acids) form a wide variety of polymeric, or complex, products (such as proteins [Fig. 8.4]). Anabolic reactions require energy (are endergonic), which is generally provided by the hydrolysis of ATP to adenosine diphosphate (ADP) and inorganic phosphate (Pi). [Note: Catabolic reactions generate energy (are exergonic).] Anabolic reactions often involve chemical reductions in which the reducing power is most frequently provided by the electron donor NADPH (phosphorylated NADH, see p. 147). II. METABOLISM REGULATION
Biochemistry_Lippincott_316
Biochemistry_Lippinco
Anabolic reactions often involve chemical reductions in which the reducing power is most frequently provided by the electron donor NADPH (phosphorylated NADH, see p. 147). II. METABOLISM REGULATION The pathways of metabolism must be coordinated so that the production of energy or the synthesis of end products meets the needs of the cell. Furthermore, individual cells function as part of a community of interacting tissues, not in isolation. Thus, a sophisticated communication system has evolved to coordinate the functions of the body. Regulatory signals that inform an individual cell of the metabolic state of the body as a whole include hormones, neurotransmitters, and the availability of nutrients. These, in turn, influence signals generated within the cell (Fig. 8.5). A. Intracellular communication
Biochemistry_Lippinco. Anabolic reactions often involve chemical reductions in which the reducing power is most frequently provided by the electron donor NADPH (phosphorylated NADH, see p. 147). II. METABOLISM REGULATION The pathways of metabolism must be coordinated so that the production of energy or the synthesis of end products meets the needs of the cell. Furthermore, individual cells function as part of a community of interacting tissues, not in isolation. Thus, a sophisticated communication system has evolved to coordinate the functions of the body. Regulatory signals that inform an individual cell of the metabolic state of the body as a whole include hormones, neurotransmitters, and the availability of nutrients. These, in turn, influence signals generated within the cell (Fig. 8.5). A. Intracellular communication
Biochemistry_Lippincott_317
Biochemistry_Lippinco
A. Intracellular communication The rate of a metabolic pathway can respond to regulatory signals that arise from within the cell. For example, the rate may be influenced by the availability of substrates, product inhibition, or alterations in the levels of allosteric activators or inhibitors. These intracellular signals typically elicit rapid responses and are important for the moment-to-moment regulation of metabolism. B. Intercellular communication
Biochemistry_Lippinco. A. Intracellular communication The rate of a metabolic pathway can respond to regulatory signals that arise from within the cell. For example, the rate may be influenced by the availability of substrates, product inhibition, or alterations in the levels of allosteric activators or inhibitors. These intracellular signals typically elicit rapid responses and are important for the moment-to-moment regulation of metabolism. B. Intercellular communication
Biochemistry_Lippincott_318
Biochemistry_Lippinco
B. Intercellular communication The ability to respond to intercellular signals is essential for the development and survival of organisms. Signaling between cells provides for long-range integration of metabolism and usually results in a response, such as a change in gene expression, that is slower than is seen with intracellular signals. Communication between cells can be mediated, for example, by surface-to-surface contact and, in some tissues, by formation of gap junctions, allowing direct communication between the cytoplasms of adjacent cells. However, for energy metabolism, the most important route of communication is chemical signaling between cells by blood-borne hormones or by neurotransmitters. C. Second messenger systems
Biochemistry_Lippinco. B. Intercellular communication The ability to respond to intercellular signals is essential for the development and survival of organisms. Signaling between cells provides for long-range integration of metabolism and usually results in a response, such as a change in gene expression, that is slower than is seen with intracellular signals. Communication between cells can be mediated, for example, by surface-to-surface contact and, in some tissues, by formation of gap junctions, allowing direct communication between the cytoplasms of adjacent cells. However, for energy metabolism, the most important route of communication is chemical signaling between cells by blood-borne hormones or by neurotransmitters. C. Second messenger systems
Biochemistry_Lippincott_319
Biochemistry_Lippinco
Hormones and neurotransmitters can be thought of as signals and their receptors as signal detectors. Receptors respond to a bound ligand by initiating a series of reactions that ultimately result in specific intracellular responses. Second messenger molecules, so named because they intervene between the original extracellular messenger (the neurotransmitter or hormone) and the ultimate intracellular effect, are part of the cascade of events that converts (transduces) ligand binding into a response. Two of the most widely recognized second messenger systems are the calcium/phosphatidylinositol system (see p. 205) and the adenylyl cyclase (adenylate cyclase) system, which is particularly important in regulating the pathways of intermediary metabolism. Both involve the binding of ligands, such as epinephrine or glucagon, to specific G protein–coupled receptors (GPCR) on the cell (plasma) membrane. GPCR are characterized by an extracellular ligand-binding domain, seven transmembrane α
Biochemistry_Lippinco. Hormones and neurotransmitters can be thought of as signals and their receptors as signal detectors. Receptors respond to a bound ligand by initiating a series of reactions that ultimately result in specific intracellular responses. Second messenger molecules, so named because they intervene between the original extracellular messenger (the neurotransmitter or hormone) and the ultimate intracellular effect, are part of the cascade of events that converts (transduces) ligand binding into a response. Two of the most widely recognized second messenger systems are the calcium/phosphatidylinositol system (see p. 205) and the adenylyl cyclase (adenylate cyclase) system, which is particularly important in regulating the pathways of intermediary metabolism. Both involve the binding of ligands, such as epinephrine or glucagon, to specific G protein–coupled receptors (GPCR) on the cell (plasma) membrane. GPCR are characterized by an extracellular ligand-binding domain, seven transmembrane α
Biochemistry_Lippincott_320
Biochemistry_Lippinco
such as epinephrine or glucagon, to specific G protein–coupled receptors (GPCR) on the cell (plasma) membrane. GPCR are characterized by an extracellular ligand-binding domain, seven transmembrane α helices, and an intracellular domain that interacts with trimeric G proteins (Fig. 8.6). [Note: Insulin, another key regulator of metabolism, binds a membrane tyrosine kinase receptor (see p. 311) and not a GPCR.]
Biochemistry_Lippinco. such as epinephrine or glucagon, to specific G protein–coupled receptors (GPCR) on the cell (plasma) membrane. GPCR are characterized by an extracellular ligand-binding domain, seven transmembrane α helices, and an intracellular domain that interacts with trimeric G proteins (Fig. 8.6). [Note: Insulin, another key regulator of metabolism, binds a membrane tyrosine kinase receptor (see p. 311) and not a GPCR.]
Biochemistry_Lippincott_321
Biochemistry_Lippinco
D. Adenylyl cyclase The recognition of a chemical signal by some GPCR, such as the β-and α2adrenergic receptors, triggers either an increase or a decrease in the activity of adenylyl cyclase (AC). This is a membrane-bound enzyme that converts ATP to 3ʹ,5ʹ-adenosine monophosphate (cyclic AMP, or cAMP). The chemical signals are most often hormones or neurotransmitters, each of which binds to a unique type of GPCR. Therefore, tissues that respond to more than one signal must have several different GPCR, each of which can be linked to AC.
Biochemistry_Lippinco. D. Adenylyl cyclase The recognition of a chemical signal by some GPCR, such as the β-and α2adrenergic receptors, triggers either an increase or a decrease in the activity of adenylyl cyclase (AC). This is a membrane-bound enzyme that converts ATP to 3ʹ,5ʹ-adenosine monophosphate (cyclic AMP, or cAMP). The chemical signals are most often hormones or neurotransmitters, each of which binds to a unique type of GPCR. Therefore, tissues that respond to more than one signal must have several different GPCR, each of which can be linked to AC.
Biochemistry_Lippincott_322
Biochemistry_Lippinco
1. Guanosine triphosphate–dependent regulatory proteins: The effect of the activated, occupied GPCR on second messenger formation is indirect, mediated by specialized trimeric proteins (α, β, and γ subunits) of the cell membrane. These proteins, referred to as G proteins because the α subunit binds guanosine di-or triphosphates (GDP or GTP), form a link in the chain of communication between the receptor and AC. In the inactive form of a G protein, the α subunit is bound to GDP (Fig. 8.7). Ligand binding causes a conformational change in the receptor, triggering replacement of this GDP with GTP. The GTP-bound form of the α subunit dissociates from the βγ subunits and moves to AC, affecting enzyme activity. Many molecules of active Gα protein are formed by one activated receptor. [Note: The ability of a hormone or neurotransmitter to stimulate or inhibit AC depends on the type of Gα protein that is linked to the receptor. One type, designated Gs, stimulates AC (see Fig. 8.7), whereas
Biochemistry_Lippinco. 1. Guanosine triphosphate–dependent regulatory proteins: The effect of the activated, occupied GPCR on second messenger formation is indirect, mediated by specialized trimeric proteins (α, β, and γ subunits) of the cell membrane. These proteins, referred to as G proteins because the α subunit binds guanosine di-or triphosphates (GDP or GTP), form a link in the chain of communication between the receptor and AC. In the inactive form of a G protein, the α subunit is bound to GDP (Fig. 8.7). Ligand binding causes a conformational change in the receptor, triggering replacement of this GDP with GTP. The GTP-bound form of the α subunit dissociates from the βγ subunits and moves to AC, affecting enzyme activity. Many molecules of active Gα protein are formed by one activated receptor. [Note: The ability of a hormone or neurotransmitter to stimulate or inhibit AC depends on the type of Gα protein that is linked to the receptor. One type, designated Gs, stimulates AC (see Fig. 8.7), whereas
Biochemistry_Lippincott_323
Biochemistry_Lippinco
ability of a hormone or neurotransmitter to stimulate or inhibit AC depends on the type of Gα protein that is linked to the receptor. One type, designated Gs, stimulates AC (see Fig. 8.7), whereas another type, designated Gi, inhibits the enzyme (not shown).] The actions of the Gα–GTP complex are short-lived because Gα has an inherent GTPase activity, resulting in the rapid hydrolysis of GTP to GDP. This causes inactivation of Gα, its dissociation from AC, and its reassociation with the βγ dimer.
Biochemistry_Lippinco. ability of a hormone or neurotransmitter to stimulate or inhibit AC depends on the type of Gα protein that is linked to the receptor. One type, designated Gs, stimulates AC (see Fig. 8.7), whereas another type, designated Gi, inhibits the enzyme (not shown).] The actions of the Gα–GTP complex are short-lived because Gα has an inherent GTPase activity, resulting in the rapid hydrolysis of GTP to GDP. This causes inactivation of Gα, its dissociation from AC, and its reassociation with the βγ dimer.
Biochemistry_Lippincott_324
Biochemistry_Lippinco
Toxins from Vibrio cholerae (cholera) and Bordetella pertussis (whooping cough) cause inappropriate activation of AC through covalent modification (ADP-ribosylation) of different G proteins. With cholera, the GTPase activity of Gαs is inhibited in intestinal cells. With whooping cough, Gαi is inactivated in respiratory tract cells.
Biochemistry_Lippinco. Toxins from Vibrio cholerae (cholera) and Bordetella pertussis (whooping cough) cause inappropriate activation of AC through covalent modification (ADP-ribosylation) of different G proteins. With cholera, the GTPase activity of Gαs is inhibited in intestinal cells. With whooping cough, Gαi is inactivated in respiratory tract cells.
Biochemistry_Lippincott_325
Biochemistry_Lippinco
2. Protein kinases: The next step in the cAMP second messenger system is the activation of a family of enzymes called cAMP-dependent protein kinases such as protein kinase A (PKA), as shown in Figure 8.8. cAMP activates PKA by binding to its two regulatory subunits, causing the release of its two catalytically active subunits. These subunits transfer phosphate from ATP to specific serine or threonine residues of protein substrates. The phosphorylated proteins may act directly on the cell’s ion channels or, if enzymes, may become activated or inhibited. [Note: Several types of protein kinases are not cAMP dependent, for example, protein kinase C, described on p. 205.] 3. Protein phosphatases: The phosphate groups added to proteins by protein kinases are removed by protein phosphatases, enzymes that hydrolytically cleave phosphate esters (see Fig. 8.8). This insures that changes in protein activity induced by phosphorylation are not permanent. 4.
Biochemistry_Lippinco. 2. Protein kinases: The next step in the cAMP second messenger system is the activation of a family of enzymes called cAMP-dependent protein kinases such as protein kinase A (PKA), as shown in Figure 8.8. cAMP activates PKA by binding to its two regulatory subunits, causing the release of its two catalytically active subunits. These subunits transfer phosphate from ATP to specific serine or threonine residues of protein substrates. The phosphorylated proteins may act directly on the cell’s ion channels or, if enzymes, may become activated or inhibited. [Note: Several types of protein kinases are not cAMP dependent, for example, protein kinase C, described on p. 205.] 3. Protein phosphatases: The phosphate groups added to proteins by protein kinases are removed by protein phosphatases, enzymes that hydrolytically cleave phosphate esters (see Fig. 8.8). This insures that changes in protein activity induced by phosphorylation are not permanent. 4.
Biochemistry_Lippincott_326
Biochemistry_Lippinco
4. cAMP hydrolysis: cAMP is rapidly hydrolyzed to 5ʹ-AMP by cAMP phosphodiesterase that cleaves the cyclic 3ʹ,5ʹ-phosphodiester bond. 5ʹAMP is not an intracellular signaling molecule. Therefore, the effects of neurotransmitter-or hormone-mediated increases of cAMP are rapidly terminated if the extracellular signal is removed. [Note: cAMP phosphodiesterase is inhibited by caffeine, a methylxanthine derivative.] III. GLYCOLYSIS OVERVIEW
Biochemistry_Lippinco. 4. cAMP hydrolysis: cAMP is rapidly hydrolyzed to 5ʹ-AMP by cAMP phosphodiesterase that cleaves the cyclic 3ʹ,5ʹ-phosphodiester bond. 5ʹAMP is not an intracellular signaling molecule. Therefore, the effects of neurotransmitter-or hormone-mediated increases of cAMP are rapidly terminated if the extracellular signal is removed. [Note: cAMP phosphodiesterase is inhibited by caffeine, a methylxanthine derivative.] III. GLYCOLYSIS OVERVIEW
Biochemistry_Lippincott_327
Biochemistry_Lippinco
The glycolytic pathway is used by all tissues for the oxidation of glucose to provide energy (as ATP) and intermediates for other metabolic pathways. Glycolysis is at the hub of carbohydrate metabolism because virtually all sugars, whether arising from the diet or from catabolic reactions in the body, can ultimately be converted to glucose (Fig. 8.9A). Pyruvate is the end product of glycolysis in cells with mitochondria and an adequate supply of O2. This series of ten reactions is called aerobic glycolysis because O2 is required to reoxidize the NADH formed during the oxidation of glyceraldehyde 3-phosphate (Fig. 8.9B). Aerobic glycolysis sets the stage for the oxidative decarboxylation of pyruvate to acetyl CoA, a major fuel of the TCA cycle. Alternatively, pyruvate is reduced to lactate as NADH is oxidized to NAD+ (Fig. 8.9C). This conversion of glucose to lactate is called anaerobic glycolysis because it can occur without the participation of O2. Anaerobic glycolysis allows the
Biochemistry_Lippinco. The glycolytic pathway is used by all tissues for the oxidation of glucose to provide energy (as ATP) and intermediates for other metabolic pathways. Glycolysis is at the hub of carbohydrate metabolism because virtually all sugars, whether arising from the diet or from catabolic reactions in the body, can ultimately be converted to glucose (Fig. 8.9A). Pyruvate is the end product of glycolysis in cells with mitochondria and an adequate supply of O2. This series of ten reactions is called aerobic glycolysis because O2 is required to reoxidize the NADH formed during the oxidation of glyceraldehyde 3-phosphate (Fig. 8.9B). Aerobic glycolysis sets the stage for the oxidative decarboxylation of pyruvate to acetyl CoA, a major fuel of the TCA cycle. Alternatively, pyruvate is reduced to lactate as NADH is oxidized to NAD+ (Fig. 8.9C). This conversion of glucose to lactate is called anaerobic glycolysis because it can occur without the participation of O2. Anaerobic glycolysis allows the
Biochemistry_Lippincott_328
Biochemistry_Lippinco
as NADH is oxidized to NAD+ (Fig. 8.9C). This conversion of glucose to lactate is called anaerobic glycolysis because it can occur without the participation of O2. Anaerobic glycolysis allows the production of ATP in tissues that lack mitochondria (for example, red blood cells [RBC] and parts of the eye) or in cells deprived of sufficient O2 (hypoxia).
Biochemistry_Lippinco. as NADH is oxidized to NAD+ (Fig. 8.9C). This conversion of glucose to lactate is called anaerobic glycolysis because it can occur without the participation of O2. Anaerobic glycolysis allows the production of ATP in tissues that lack mitochondria (for example, red blood cells [RBC] and parts of the eye) or in cells deprived of sufficient O2 (hypoxia).
Biochemistry_Lippincott_329
Biochemistry_Lippinco
IV. GLUCOSE TRANSPORT INTO CELLS Glucose cannot diffuse directly into cells but enters by one of two transport systems: a sodium (Na+)-and ATP-independent transport system or a Na+-and ATP-dependent cotransport system. A. Sodium-and ATP-independent transport system This passive system is mediated by a family of 14 glucose transporter (GLUT) isoforms found in cell membranes. They are designated GLUT-1 to GLUT-14. These monomeric protein transporters exist in the membrane in two conformational states (Fig. 8.10). Extracellular glucose binds to the transporter, which then alters its conformation, transporting glucose across the cell membrane via facilitated diffusion. Because GLUT transport one molecule at a time, they are uniporters. 1. Tissue specificity: GLUT display a tissue-specific pattern of expression.
Biochemistry_Lippinco. IV. GLUCOSE TRANSPORT INTO CELLS Glucose cannot diffuse directly into cells but enters by one of two transport systems: a sodium (Na+)-and ATP-independent transport system or a Na+-and ATP-dependent cotransport system. A. Sodium-and ATP-independent transport system This passive system is mediated by a family of 14 glucose transporter (GLUT) isoforms found in cell membranes. They are designated GLUT-1 to GLUT-14. These monomeric protein transporters exist in the membrane in two conformational states (Fig. 8.10). Extracellular glucose binds to the transporter, which then alters its conformation, transporting glucose across the cell membrane via facilitated diffusion. Because GLUT transport one molecule at a time, they are uniporters. 1. Tissue specificity: GLUT display a tissue-specific pattern of expression.
Biochemistry_Lippincott_330
Biochemistry_Lippinco
1. Tissue specificity: GLUT display a tissue-specific pattern of expression. For example, GLUT-3 is the primary isoform in neurons. GLUT-1 is abundant in RBC and the blood–brain barrier but is low in adult muscle, whereas GLUT-4 is abundant in muscle and adipose tissue. [Note: The number of GLUT-4 transporters active in these tissues is increased by insulin. (See p. 311 for a discussion of insulin and glucose transport.)] GLUT-2 is abundant in the liver, kidneys, and pancreatic β cells. The other GLUT isoforms also have tissue-specific distributions. 2.
Biochemistry_Lippinco. 1. Tissue specificity: GLUT display a tissue-specific pattern of expression. For example, GLUT-3 is the primary isoform in neurons. GLUT-1 is abundant in RBC and the blood–brain barrier but is low in adult muscle, whereas GLUT-4 is abundant in muscle and adipose tissue. [Note: The number of GLUT-4 transporters active in these tissues is increased by insulin. (See p. 311 for a discussion of insulin and glucose transport.)] GLUT-2 is abundant in the liver, kidneys, and pancreatic β cells. The other GLUT isoforms also have tissue-specific distributions. 2.
Biochemistry_Lippincott_331
Biochemistry_Lippinco
2. Specialized functions: In facilitated diffusion, transporter-mediated glucose movement is down a concentration gradient (that is, from a high concentration to a lower one, therefore requiring no energy). For example, GLUT-1, GLUT-3, and GLUT-4 are primarily involved in glucose uptake from the blood. In contrast, GLUT-2, in the liver and kidneys, can either transport glucose into these cells when blood glucose levels are high or transport glucose from these cells when blood glucose levels are low (for example, during fasting). GLUT-5 is unusual in that it is the primary transporter for fructose (not glucose) in the small intestine and the testes (see p. 87). B. Sodium-and ATP-dependent cotransport system
Biochemistry_Lippinco. 2. Specialized functions: In facilitated diffusion, transporter-mediated glucose movement is down a concentration gradient (that is, from a high concentration to a lower one, therefore requiring no energy). For example, GLUT-1, GLUT-3, and GLUT-4 are primarily involved in glucose uptake from the blood. In contrast, GLUT-2, in the liver and kidneys, can either transport glucose into these cells when blood glucose levels are high or transport glucose from these cells when blood glucose levels are low (for example, during fasting). GLUT-5 is unusual in that it is the primary transporter for fructose (not glucose) in the small intestine and the testes (see p. 87). B. Sodium-and ATP-dependent cotransport system
Biochemistry_Lippincott_332
Biochemistry_Lippinco
B. Sodium-and ATP-dependent cotransport system This energy-requiring process transports glucose against (up) its concentration gradient (that is, from low extracellular concentrations to higher intracellular concentrations) as Na+ is transported down its electrochemical gradient. [Note: The gradient is created by the Na+potassium (K+) ATPase (see Fig. 7.10, p. 87).] Because this secondary active transport process requires the concurrent uptake (symport) of Na+, the transporter is a sodium-dependent glucose cotransporter (SGLT). This type of cotransport occurs in the epithelial cells of the intestine (see p. 87), renal tubules, and choroid plexus. [Note: The choroid plexus, part of the blood–brain barrier, also contains GLUT-1.] V. GLYCOLYSIS REACTIONS
Biochemistry_Lippinco. B. Sodium-and ATP-dependent cotransport system This energy-requiring process transports glucose against (up) its concentration gradient (that is, from low extracellular concentrations to higher intracellular concentrations) as Na+ is transported down its electrochemical gradient. [Note: The gradient is created by the Na+potassium (K+) ATPase (see Fig. 7.10, p. 87).] Because this secondary active transport process requires the concurrent uptake (symport) of Na+, the transporter is a sodium-dependent glucose cotransporter (SGLT). This type of cotransport occurs in the epithelial cells of the intestine (see p. 87), renal tubules, and choroid plexus. [Note: The choroid plexus, part of the blood–brain barrier, also contains GLUT-1.] V. GLYCOLYSIS REACTIONS
Biochemistry_Lippincott_333
Biochemistry_Lippinco
V. GLYCOLYSIS REACTIONS The conversion of glucose to pyruvate occurs in two stages (Fig. 8.11). The first five reactions of glycolysis correspond to an energy-investment phase in which the phosphorylated forms of intermediates are synthesized at the expense of ATP. The subsequent reactions of glycolysis constitute an energy-generation phase in which a net of two molecules of ATP are formed by substrate-level phosphorylation (see p. 102) per glucose molecule metabolized. A. Glucose phosphorylation Phosphorylated sugar molecules do not readily penetrate cell membranes because there are no specific transmembrane carriers for these compounds and because they are too polar to diffuse through the lipid core of membranes. Therefore, the irreversible phosphorylation of glucose (Fig.
Biochemistry_Lippinco. V. GLYCOLYSIS REACTIONS The conversion of glucose to pyruvate occurs in two stages (Fig. 8.11). The first five reactions of glycolysis correspond to an energy-investment phase in which the phosphorylated forms of intermediates are synthesized at the expense of ATP. The subsequent reactions of glycolysis constitute an energy-generation phase in which a net of two molecules of ATP are formed by substrate-level phosphorylation (see p. 102) per glucose molecule metabolized. A. Glucose phosphorylation Phosphorylated sugar molecules do not readily penetrate cell membranes because there are no specific transmembrane carriers for these compounds and because they are too polar to diffuse through the lipid core of membranes. Therefore, the irreversible phosphorylation of glucose (Fig.
Biochemistry_Lippincott_334
Biochemistry_Lippinco
8.12) effectively traps the sugar as cytosolic glucose 6-phosphate and commits it to further metabolism in the cell. Mammals have four isozymes (I–IV) of the enzyme hexokinase that catalyze the phosphorylation of glucose to glucose 6-phosphate.
Biochemistry_Lippinco. 8.12) effectively traps the sugar as cytosolic glucose 6-phosphate and commits it to further metabolism in the cell. Mammals have four isozymes (I–IV) of the enzyme hexokinase that catalyze the phosphorylation of glucose to glucose 6-phosphate.
Biochemistry_Lippincott_335
Biochemistry_Lippinco
1. Hexokinases I–III: In most tissues, glucose phosphorylation is catalyzed by one of these isozymes of hexokinase, which is one of three regulatory enzymes of glycolysis (along with phosphofructokinase and pyruvate kinase). They are inhibited by the reaction product glucose 6-phosphate, which accumulates when further metabolism of this hexose phosphate is reduced. Hexokinases I–III have a low Michaelis constant (Km) and, therefore, a high affinity (see p. 59) for glucose. This permits the efficient phosphorylation and subsequent metabolism of glucose even when tissue concentrations of glucose are low (Fig. 8.13). However, because these isozymes have a low maximal velocity ([Vmax] see p. 57) for glucose, they do not sequester (trap) cellular phosphate in the form of phosphorylated glucose or phosphorylate more glucose than the cell can use. [Note: These isozymes have broad substrate specificity and are able to phosphorylate several hexoses in addition to glucose.] 2. Hexokinase IV: In
Biochemistry_Lippinco. 1. Hexokinases I–III: In most tissues, glucose phosphorylation is catalyzed by one of these isozymes of hexokinase, which is one of three regulatory enzymes of glycolysis (along with phosphofructokinase and pyruvate kinase). They are inhibited by the reaction product glucose 6-phosphate, which accumulates when further metabolism of this hexose phosphate is reduced. Hexokinases I–III have a low Michaelis constant (Km) and, therefore, a high affinity (see p. 59) for glucose. This permits the efficient phosphorylation and subsequent metabolism of glucose even when tissue concentrations of glucose are low (Fig. 8.13). However, because these isozymes have a low maximal velocity ([Vmax] see p. 57) for glucose, they do not sequester (trap) cellular phosphate in the form of phosphorylated glucose or phosphorylate more glucose than the cell can use. [Note: These isozymes have broad substrate specificity and are able to phosphorylate several hexoses in addition to glucose.] 2. Hexokinase IV: In
Biochemistry_Lippincott_336
Biochemistry_Lippinco
or phosphorylate more glucose than the cell can use. [Note: These isozymes have broad substrate specificity and are able to phosphorylate several hexoses in addition to glucose.] 2. Hexokinase IV: In liver parenchymal cells and pancreatic β cells, glucokinase (the hexokinase IV isozyme) is the predominant enzyme responsible for glucose phosphorylation. In β cells, glucokinase functions as a glucose sensor, determining the threshold for insulin secretion (see p. 309). [Note: Hexokinase IV also serves as a glucose sensor in hypothalamic neurons, playing a key role in the adrenergic response to hypoglycemia (see p. 315).] In the liver, the enzyme facilitates glucose phosphorylation during hyperglycemia. Despite the popular but misleading name glucokinase, the sugar specificity of the enzyme is similar to that of other hexokinase isozymes.
Biochemistry_Lippinco. or phosphorylate more glucose than the cell can use. [Note: These isozymes have broad substrate specificity and are able to phosphorylate several hexoses in addition to glucose.] 2. Hexokinase IV: In liver parenchymal cells and pancreatic β cells, glucokinase (the hexokinase IV isozyme) is the predominant enzyme responsible for glucose phosphorylation. In β cells, glucokinase functions as a glucose sensor, determining the threshold for insulin secretion (see p. 309). [Note: Hexokinase IV also serves as a glucose sensor in hypothalamic neurons, playing a key role in the adrenergic response to hypoglycemia (see p. 315).] In the liver, the enzyme facilitates glucose phosphorylation during hyperglycemia. Despite the popular but misleading name glucokinase, the sugar specificity of the enzyme is similar to that of other hexokinase isozymes.
Biochemistry_Lippincott_337
Biochemistry_Lippinco
a. Kinetics: Glucokinase differs from hexokinases I–III in several important properties. For example, it has a much higher Km, requiring a higher glucose concentration for half-saturation (see Fig. 8.13). Thus, glucokinase functions only when the intracellular concentration of glucose in the hepatocyte is elevated such as during the brief period following consumption of a carbohydrate-rich meal, when high levels of glucose are delivered to the liver via the portal vein. Glucokinase has a high Vmax, allowing the liver to effectively remove the flood of glucose delivered by the portal blood. This prevents large amounts of glucose from entering the systemic circulation following such a meal, thereby minimizing hyperglycemia during the absorptive period. [Note: GLUT-2 insures that blood glucose equilibrates rapidly across the hepatocyte membrane.] b. Regulation: Glucokinase activity is not directly inhibited by glucose 6phosphate as are the other hexokinases. Instead, it is indirectly
Biochemistry_Lippinco. a. Kinetics: Glucokinase differs from hexokinases I–III in several important properties. For example, it has a much higher Km, requiring a higher glucose concentration for half-saturation (see Fig. 8.13). Thus, glucokinase functions only when the intracellular concentration of glucose in the hepatocyte is elevated such as during the brief period following consumption of a carbohydrate-rich meal, when high levels of glucose are delivered to the liver via the portal vein. Glucokinase has a high Vmax, allowing the liver to effectively remove the flood of glucose delivered by the portal blood. This prevents large amounts of glucose from entering the systemic circulation following such a meal, thereby minimizing hyperglycemia during the absorptive period. [Note: GLUT-2 insures that blood glucose equilibrates rapidly across the hepatocyte membrane.] b. Regulation: Glucokinase activity is not directly inhibited by glucose 6phosphate as are the other hexokinases. Instead, it is indirectly
Biochemistry_Lippincott_338
Biochemistry_Lippinco
equilibrates rapidly across the hepatocyte membrane.] b. Regulation: Glucokinase activity is not directly inhibited by glucose 6phosphate as are the other hexokinases. Instead, it is indirectly inhibited by fructose 6-phosphate (which is in equilibrium with glucose 6-phosphate, a product of glucokinase) and is indirectly stimulated by glucose (a substrate of glucokinase). Regulation is achieved by reversible binding to the hepatic protein glucokinase regulatory protein (GKRP). In the presence of fructose 6-phosphate, glucokinase binds tightly to GKRP and is translocated to the nucleus, thereby rendering the enzyme inactive (Fig. 8.14). When glucose levels in the blood (and also in the hepatocyte, as a result of GLUT-2) increase, glucokinase is released from GKRP, and the enzyme reenters the cytosol where it phosphorylates glucose to glucose 6-phosphate. [Note: GKRP is a competitive inhibitor of glucose use by glucokinase.]
Biochemistry_Lippinco. equilibrates rapidly across the hepatocyte membrane.] b. Regulation: Glucokinase activity is not directly inhibited by glucose 6phosphate as are the other hexokinases. Instead, it is indirectly inhibited by fructose 6-phosphate (which is in equilibrium with glucose 6-phosphate, a product of glucokinase) and is indirectly stimulated by glucose (a substrate of glucokinase). Regulation is achieved by reversible binding to the hepatic protein glucokinase regulatory protein (GKRP). In the presence of fructose 6-phosphate, glucokinase binds tightly to GKRP and is translocated to the nucleus, thereby rendering the enzyme inactive (Fig. 8.14). When glucose levels in the blood (and also in the hepatocyte, as a result of GLUT-2) increase, glucokinase is released from GKRP, and the enzyme reenters the cytosol where it phosphorylates glucose to glucose 6-phosphate. [Note: GKRP is a competitive inhibitor of glucose use by glucokinase.]
Biochemistry_Lippincott_339
Biochemistry_Lippinco
Glucokinase functions as a glucose sensor in blood glucose homeostasis. Inactivating mutations of glucokinase are the cause of a rare form of diabetes, maturity onset diabetes of the young type 2 (MODY 2) that is characterized by impaired insulin secretion and hyperglycemia. B. Glucose 6-phosphate isomerization The isomerization of glucose 6-phosphate to fructose 6-phosphate is catalyzed by phosphoglucose isomerase (Fig. 8.15). The reaction is readily reversible and is not a rate-limiting or regulated step. C. Fructose 6-phosphate phosphorylation The irreversible phosphorylation reaction catalyzed by phosphofructokinase-1 (PFK-1) is the most important control point and the rate-limiting and committed step of glycolysis (Fig. 8.16). PFK-1 is controlled by the available concentrations of the substrates ATP and fructose 6-phosphate as well as by other regulatory molecules. 1.
Biochemistry_Lippinco. Glucokinase functions as a glucose sensor in blood glucose homeostasis. Inactivating mutations of glucokinase are the cause of a rare form of diabetes, maturity onset diabetes of the young type 2 (MODY 2) that is characterized by impaired insulin secretion and hyperglycemia. B. Glucose 6-phosphate isomerization The isomerization of glucose 6-phosphate to fructose 6-phosphate is catalyzed by phosphoglucose isomerase (Fig. 8.15). The reaction is readily reversible and is not a rate-limiting or regulated step. C. Fructose 6-phosphate phosphorylation The irreversible phosphorylation reaction catalyzed by phosphofructokinase-1 (PFK-1) is the most important control point and the rate-limiting and committed step of glycolysis (Fig. 8.16). PFK-1 is controlled by the available concentrations of the substrates ATP and fructose 6-phosphate as well as by other regulatory molecules. 1.
Biochemistry_Lippincott_340
Biochemistry_Lippinco
1. Regulation by intracellular energy levels: PFK-1 is inhibited allosterically by elevated levels of ATP, which act as an energy-rich signal indicating an abundance of high-energy compounds. Elevated levels of citrate, an intermediate in the TCA cycle (see p. 111), also inhibit PFK-1. [Note: Inhibition by citrate favors the use of glucose for glycogen synthesis (see p. 126).] Conversely, PFK-1 is activated allosterically by high concentrations of AMP, which signal that the cell’s energy stores are depleted. 2.
Biochemistry_Lippinco. 1. Regulation by intracellular energy levels: PFK-1 is inhibited allosterically by elevated levels of ATP, which act as an energy-rich signal indicating an abundance of high-energy compounds. Elevated levels of citrate, an intermediate in the TCA cycle (see p. 111), also inhibit PFK-1. [Note: Inhibition by citrate favors the use of glucose for glycogen synthesis (see p. 126).] Conversely, PFK-1 is activated allosterically by high concentrations of AMP, which signal that the cell’s energy stores are depleted. 2.
Biochemistry_Lippincott_341
Biochemistry_Lippinco
Regulation by fructose 2,6-bisphosphate: Fructose 2,6-bisphosphate is the most potent activator of PFK-1 (see Fig. 8.16) and is able to activate the enzyme even when ATP levels are high. It is formed from fructose 6phosphate by phosphofructokinase-2 (PFK-2). Unlike PFK-1, PFK-2 is a bifunctional protein that has both the kinase activity that produces fructose 2,6-bisphosphate and the phosphatase activity that dephosphorylates fructose 2,6-bisphosphate to fructose 6-phosphate. In the liver isozyme, phosphorylation of PFK-2 inactivates the kinase domain and activates the phosphatase domain (Fig. 8.17). The opposite is seen in the cardiac isozyme. Skeletal PFK-2 is not covalently regulated. [Note: Fructose 2,6-bisphosphate is an inhibitor of fructose 1,6-bisphosphatase, an enzyme of gluconeogenesis (see p. 121). The reciprocal actions of fructose 2,6-bisphosphate on glycolysis (activation) and gluconeogenesis (inhibition) insure that both pathways are not fully active at the same time,
Biochemistry_Lippinco. Regulation by fructose 2,6-bisphosphate: Fructose 2,6-bisphosphate is the most potent activator of PFK-1 (see Fig. 8.16) and is able to activate the enzyme even when ATP levels are high. It is formed from fructose 6phosphate by phosphofructokinase-2 (PFK-2). Unlike PFK-1, PFK-2 is a bifunctional protein that has both the kinase activity that produces fructose 2,6-bisphosphate and the phosphatase activity that dephosphorylates fructose 2,6-bisphosphate to fructose 6-phosphate. In the liver isozyme, phosphorylation of PFK-2 inactivates the kinase domain and activates the phosphatase domain (Fig. 8.17). The opposite is seen in the cardiac isozyme. Skeletal PFK-2 is not covalently regulated. [Note: Fructose 2,6-bisphosphate is an inhibitor of fructose 1,6-bisphosphatase, an enzyme of gluconeogenesis (see p. 121). The reciprocal actions of fructose 2,6-bisphosphate on glycolysis (activation) and gluconeogenesis (inhibition) insure that both pathways are not fully active at the same time,
Biochemistry_Lippincott_342
Biochemistry_Lippinco
(see p. 121). The reciprocal actions of fructose 2,6-bisphosphate on glycolysis (activation) and gluconeogenesis (inhibition) insure that both pathways are not fully active at the same time, preventing a futile cycle of glucose oxidation to pyruvate followed by glucose resynthesis from pyruvate.] a.
Biochemistry_Lippinco. (see p. 121). The reciprocal actions of fructose 2,6-bisphosphate on glycolysis (activation) and gluconeogenesis (inhibition) insure that both pathways are not fully active at the same time, preventing a futile cycle of glucose oxidation to pyruvate followed by glucose resynthesis from pyruvate.] a.
Biochemistry_Lippincott_343
Biochemistry_Lippinco
During the well-fed state: Decreased levels of glucagon and elevated levels of insulin (such as occur following a carbohydrate-rich meal) cause an increase in hepatic fructose 2,6-bisphos-phate (PFK-2 is dephosphorylated) and, thus, in the rate of glycolysis (see Fig. 8.17). Therefore, fructose 2,6-bisphosphate acts as an intracellular signal of glucose abundance. b. During fasting: By contrast, the elevated levels of glucagon and low levels of insulin that occur during fasting (see p. 327) cause a decrease in hepatic fructose 2,6-bisphosphate (PFK-2 is phosphorylated). This results in inhibition of glycolysis and activation of gluconeogenesis. D. Fructose 1,6-bisphosphate cleavage
Biochemistry_Lippinco. During the well-fed state: Decreased levels of glucagon and elevated levels of insulin (such as occur following a carbohydrate-rich meal) cause an increase in hepatic fructose 2,6-bisphos-phate (PFK-2 is dephosphorylated) and, thus, in the rate of glycolysis (see Fig. 8.17). Therefore, fructose 2,6-bisphosphate acts as an intracellular signal of glucose abundance. b. During fasting: By contrast, the elevated levels of glucagon and low levels of insulin that occur during fasting (see p. 327) cause a decrease in hepatic fructose 2,6-bisphosphate (PFK-2 is phosphorylated). This results in inhibition of glycolysis and activation of gluconeogenesis. D. Fructose 1,6-bisphosphate cleavage
Biochemistry_Lippincott_344
Biochemistry_Lippinco
D. Fructose 1,6-bisphosphate cleavage Aldolase cleaves fructose 1,6-bisphosphate to dihydroxyacetone phosphate (DHAP) and glyceraldehyde 3-phosphate (see Fig. 8.16). The reaction is reversible and not regulated. [Note: Aldolase B, the hepatic isoform, also cleaves fructose 1-phosphate and functions in dietary fructose metabolism (see p. 138).] E. Dihydroxyacetone phosphate isomerization Triose phosphate isomerase interconverts DHAP and glyceraldehyde 3phosphate (see Fig. 8.16). DHAP must be isomerized to glyceraldehyde 3phosphate for further metabolism by the glycolytic pathway. This isomerization results in the net production of two molecules of glyceraldehyde 3-phosphate from the cleavage products of fructose 1,6bisphosphate. [Note: DHAP is utilized in triacylglycerol synthesis (see p. 188).] F. Glyceraldehyde 3-phosphate oxidation
Biochemistry_Lippinco. D. Fructose 1,6-bisphosphate cleavage Aldolase cleaves fructose 1,6-bisphosphate to dihydroxyacetone phosphate (DHAP) and glyceraldehyde 3-phosphate (see Fig. 8.16). The reaction is reversible and not regulated. [Note: Aldolase B, the hepatic isoform, also cleaves fructose 1-phosphate and functions in dietary fructose metabolism (see p. 138).] E. Dihydroxyacetone phosphate isomerization Triose phosphate isomerase interconverts DHAP and glyceraldehyde 3phosphate (see Fig. 8.16). DHAP must be isomerized to glyceraldehyde 3phosphate for further metabolism by the glycolytic pathway. This isomerization results in the net production of two molecules of glyceraldehyde 3-phosphate from the cleavage products of fructose 1,6bisphosphate. [Note: DHAP is utilized in triacylglycerol synthesis (see p. 188).] F. Glyceraldehyde 3-phosphate oxidation
Biochemistry_Lippincott_345
Biochemistry_Lippinco
F. Glyceraldehyde 3-phosphate oxidation The conversion of glyceraldehyde 3-phosphate to 1,3-bisphosphoglycerate (1,3-BPG) by glyceraldehyde 3-phosphate dehydrogenase is the first oxidation-reduction reaction of glycolysis (Fig. 8.18). [Note: Because there is a limited amount of NAD+ in the cell, the NADH formed by the dehydrogenase reaction must be oxidized for glycolysis to continue. Two major mechanisms for oxidizing NADH to NAD+ are the reduction of pyruvate to lactate by lactate dehydrogenase (LDH) (anaerobic, see p. 96) and the electron transport chain ([ETC] aerobic, see p. 74). Because NADH cannot cross the inner mitochondrial membrane, the ETC requires the malate-aspartate and glycerol 3-phosphate substrate shuttles to move NADH reducing equivalents into the mitochondrial matrix (see p. 79).] 1.
Biochemistry_Lippinco. F. Glyceraldehyde 3-phosphate oxidation The conversion of glyceraldehyde 3-phosphate to 1,3-bisphosphoglycerate (1,3-BPG) by glyceraldehyde 3-phosphate dehydrogenase is the first oxidation-reduction reaction of glycolysis (Fig. 8.18). [Note: Because there is a limited amount of NAD+ in the cell, the NADH formed by the dehydrogenase reaction must be oxidized for glycolysis to continue. Two major mechanisms for oxidizing NADH to NAD+ are the reduction of pyruvate to lactate by lactate dehydrogenase (LDH) (anaerobic, see p. 96) and the electron transport chain ([ETC] aerobic, see p. 74). Because NADH cannot cross the inner mitochondrial membrane, the ETC requires the malate-aspartate and glycerol 3-phosphate substrate shuttles to move NADH reducing equivalents into the mitochondrial matrix (see p. 79).] 1.
Biochemistry_Lippincott_346
Biochemistry_Lippinco
1,3-Bisphosphoglycerate synthesis: The oxidation of the aldehyde group of glyceraldehyde 3-phosphate to a carboxyl group is coupled to the attachment of Pi to the carboxyl group. This phosphate group, linked to carbon 1 of the 1,3-BPG product by a high-energy bond (see p. 73), conserves much of the free energy (see p. 69) produced by the oxidation of glyceraldehyde 3-phosphate. This high-energy phosphate drives ATP synthesis in the next reaction of glycolysis. 2.
Biochemistry_Lippinco. 1,3-Bisphosphoglycerate synthesis: The oxidation of the aldehyde group of glyceraldehyde 3-phosphate to a carboxyl group is coupled to the attachment of Pi to the carboxyl group. This phosphate group, linked to carbon 1 of the 1,3-BPG product by a high-energy bond (see p. 73), conserves much of the free energy (see p. 69) produced by the oxidation of glyceraldehyde 3-phosphate. This high-energy phosphate drives ATP synthesis in the next reaction of glycolysis. 2.
Biochemistry_Lippincott_347
Biochemistry_Lippinco
Arsenic poisoning: The toxicity of arsenic is due primarily to the inhibition by trivalent arsenic (arsenite) of enzymes such as the pyruvate dehydrogenase complex (PDHC), which require lipoic acid as a coenzyme (see p. 110). However, pentavalent arsenic (arsenate) can prevent net ATP and NADH production by glycolysis without inhibiting the pathway itself. It does so by competing with Pi as a substrate for glyceraldehyde 3-phosphate dehydrogenase, forming a complex that spontaneously hydrolyzes to form 3-phosphoglycerate (see Fig. 8.18). By bypassing the synthesis of and phosphate transfer from 1,3-BPG, the cell is deprived of energy usually obtained from the glycolytic pathway. [Note: Arsenate also competes with Pi binding to the F1 domain of ATP synthase (see p. 78), resulting in formation of ADP-arsenate that is rapidly hydrolyzed.] 3. 2,3-Bisphosphoglycerate synthesis in RBC: Some of the 1,3-BPG is converted to 2,3-BPG by the action of bisphosphoglycerate mutase (see Fig. 8.18).
Biochemistry_Lippinco. Arsenic poisoning: The toxicity of arsenic is due primarily to the inhibition by trivalent arsenic (arsenite) of enzymes such as the pyruvate dehydrogenase complex (PDHC), which require lipoic acid as a coenzyme (see p. 110). However, pentavalent arsenic (arsenate) can prevent net ATP and NADH production by glycolysis without inhibiting the pathway itself. It does so by competing with Pi as a substrate for glyceraldehyde 3-phosphate dehydrogenase, forming a complex that spontaneously hydrolyzes to form 3-phosphoglycerate (see Fig. 8.18). By bypassing the synthesis of and phosphate transfer from 1,3-BPG, the cell is deprived of energy usually obtained from the glycolytic pathway. [Note: Arsenate also competes with Pi binding to the F1 domain of ATP synthase (see p. 78), resulting in formation of ADP-arsenate that is rapidly hydrolyzed.] 3. 2,3-Bisphosphoglycerate synthesis in RBC: Some of the 1,3-BPG is converted to 2,3-BPG by the action of bisphosphoglycerate mutase (see Fig. 8.18).
Biochemistry_Lippincott_348
Biochemistry_Lippinco
of ADP-arsenate that is rapidly hydrolyzed.] 3. 2,3-Bisphosphoglycerate synthesis in RBC: Some of the 1,3-BPG is converted to 2,3-BPG by the action of bisphosphoglycerate mutase (see Fig. 8.18). 2,3-BPG, which is found in only trace amounts in most cells, is present at high concentration in RBC and serves to increase O2 delivery (see p. 31). 2,3-BPG is hydrolyzed by a phosphatase to 3phosphoglycerate, which is also an intermediate in glycolysis (see Fig. 8.18). In the RBC, glycolysis is modified by inclusion of these shunt reactions.
Biochemistry_Lippinco. of ADP-arsenate that is rapidly hydrolyzed.] 3. 2,3-Bisphosphoglycerate synthesis in RBC: Some of the 1,3-BPG is converted to 2,3-BPG by the action of bisphosphoglycerate mutase (see Fig. 8.18). 2,3-BPG, which is found in only trace amounts in most cells, is present at high concentration in RBC and serves to increase O2 delivery (see p. 31). 2,3-BPG is hydrolyzed by a phosphatase to 3phosphoglycerate, which is also an intermediate in glycolysis (see Fig. 8.18). In the RBC, glycolysis is modified by inclusion of these shunt reactions.
Biochemistry_Lippincott_349
Biochemistry_Lippinco
G. 3-Phosphoglycerate synthesis and ATP production When 1,3-BPG is converted to 3-phosphoglycerate, the high-energy phosphate group of 1,3-BPG is used to synthesize ATP from ADP (see Fig. 8.18). This reaction is catalyzed by phosphoglycerate kinase, which, unlike most other kinases, is physiologically reversible. Because two molecules of 1,3-BPG are formed from each glucose molecule, this kinase reaction replaces the two ATP molecules consumed by the earlier formation of glucose 6-phosphate and fructose 1,6-bisphosphate. [Note: This reaction is an example of substrate-level phosphorylation, in which the energy needed for the production of a high-energy phosphate comes from a substrate rather than from the ETC (see J. below and p. 113 for other examples).] H. Phosphate group shift The shift of the phosphate group from carbon 3 to carbon 2 of phosphoglycerate by phosphoglycerate mutase is freely reversible. I. 2-Phosphoglycerate dehydration
Biochemistry_Lippinco. G. 3-Phosphoglycerate synthesis and ATP production When 1,3-BPG is converted to 3-phosphoglycerate, the high-energy phosphate group of 1,3-BPG is used to synthesize ATP from ADP (see Fig. 8.18). This reaction is catalyzed by phosphoglycerate kinase, which, unlike most other kinases, is physiologically reversible. Because two molecules of 1,3-BPG are formed from each glucose molecule, this kinase reaction replaces the two ATP molecules consumed by the earlier formation of glucose 6-phosphate and fructose 1,6-bisphosphate. [Note: This reaction is an example of substrate-level phosphorylation, in which the energy needed for the production of a high-energy phosphate comes from a substrate rather than from the ETC (see J. below and p. 113 for other examples).] H. Phosphate group shift The shift of the phosphate group from carbon 3 to carbon 2 of phosphoglycerate by phosphoglycerate mutase is freely reversible. I. 2-Phosphoglycerate dehydration
Biochemistry_Lippincott_350
Biochemistry_Lippinco
H. Phosphate group shift The shift of the phosphate group from carbon 3 to carbon 2 of phosphoglycerate by phosphoglycerate mutase is freely reversible. I. 2-Phosphoglycerate dehydration The dehydration of 2-phosphoglycerate by enolase redistributes the energy within the substrate, forming phosphoenolpyruvate (PEP), which contains a high-energy enol phosphate (see Fig. 8.18). The reaction is reversible, despite the high-energy nature of the product. [Note: Fluoride inhibits enolase, and water fluoridation reduces lactate production by mouth bacteria, decreasing dental caries (see p. 405).] J. Pyruvate synthesis and ATP production The conversion of PEP to pyruvate, catalyzed by pyruvate kinase (PK), is the third irreversible reaction of glycolysis. The high-energy enol phosphate in PEP is used to synthesize ATP from ADP and is another example of substrate-level phosphorylation (see Fig. 8.18). 1.
Biochemistry_Lippinco. H. Phosphate group shift The shift of the phosphate group from carbon 3 to carbon 2 of phosphoglycerate by phosphoglycerate mutase is freely reversible. I. 2-Phosphoglycerate dehydration The dehydration of 2-phosphoglycerate by enolase redistributes the energy within the substrate, forming phosphoenolpyruvate (PEP), which contains a high-energy enol phosphate (see Fig. 8.18). The reaction is reversible, despite the high-energy nature of the product. [Note: Fluoride inhibits enolase, and water fluoridation reduces lactate production by mouth bacteria, decreasing dental caries (see p. 405).] J. Pyruvate synthesis and ATP production The conversion of PEP to pyruvate, catalyzed by pyruvate kinase (PK), is the third irreversible reaction of glycolysis. The high-energy enol phosphate in PEP is used to synthesize ATP from ADP and is another example of substrate-level phosphorylation (see Fig. 8.18). 1.
Biochemistry_Lippincott_351
Biochemistry_Lippinco
1. Feedforward regulation: PK is activated by fructose 1,6-bisphosphate, the product of the PFK-1 reaction. This feedforward (instead of the more usual feedback) regulation has the effect of linking the two kinase activities: increased PFK-1 activity results in elevated levels of fructose 1,6-bisphosphate, which activates PK. [Note: PK is inhibited by ATP.] 2. Covalent regulation in the liver: Phosphorylation by cAMP-dependent PKA leads to inactivation of the hepatic isozyme of PK (Fig. 8.19). When blood glucose levels are low, elevated glucagon increases the intracellular level of cAMP, which causes the phosphorylation and inactivation of PK in the liver only. Therefore, PEP is unable to continue in glycolysis and, instead, enters the gluconeogenesis pathway. This partly explains the observed inhibition of hepatic glycolysis and stimulation of gluconeogenesis by glucagon. Dephosphorylation of PK by a phosphatase results in reactivation of the enzyme. diphosphate.
Biochemistry_Lippinco. 1. Feedforward regulation: PK is activated by fructose 1,6-bisphosphate, the product of the PFK-1 reaction. This feedforward (instead of the more usual feedback) regulation has the effect of linking the two kinase activities: increased PFK-1 activity results in elevated levels of fructose 1,6-bisphosphate, which activates PK. [Note: PK is inhibited by ATP.] 2. Covalent regulation in the liver: Phosphorylation by cAMP-dependent PKA leads to inactivation of the hepatic isozyme of PK (Fig. 8.19). When blood glucose levels are low, elevated glucagon increases the intracellular level of cAMP, which causes the phosphorylation and inactivation of PK in the liver only. Therefore, PEP is unable to continue in glycolysis and, instead, enters the gluconeogenesis pathway. This partly explains the observed inhibition of hepatic glycolysis and stimulation of gluconeogenesis by glucagon. Dephosphorylation of PK by a phosphatase results in reactivation of the enzyme. diphosphate.
Biochemistry_Lippincott_352
Biochemistry_Lippinco
3. Pyruvate kinase deficiency: Because mature RBC lack mitochondria, they are completely dependent on glycolysis for ATP production. ATP is required to meet the metabolic needs of RBC and to fuel the ion pumps necessary for the maintenance of the flexible, biconcave shape that allows them to squeeze through narrow capillaries. The anemia observed in glycolytic enzyme deficiencies is a consequence of the reduced rate of glycolysis, leading to decreased ATP production by substrate-level phosphorylation. The resulting alterations in the RBC membrane lead to changes in cell shape and, ultimately, to phagocytosis by cells of the mononuclear phagocyte system, particularly splenic macrophages. The premature death and lysis of RBC result in mild-to-severe nonspherocytic hemolytic anemia, with the severe form requiring regular transfusions. Among patients with rare genetic defects of glycolytic enzymes, the majority has a deficiency in PK. [Note: Liver PK is encoded by the same gene as the RBC
Biochemistry_Lippinco. 3. Pyruvate kinase deficiency: Because mature RBC lack mitochondria, they are completely dependent on glycolysis for ATP production. ATP is required to meet the metabolic needs of RBC and to fuel the ion pumps necessary for the maintenance of the flexible, biconcave shape that allows them to squeeze through narrow capillaries. The anemia observed in glycolytic enzyme deficiencies is a consequence of the reduced rate of glycolysis, leading to decreased ATP production by substrate-level phosphorylation. The resulting alterations in the RBC membrane lead to changes in cell shape and, ultimately, to phagocytosis by cells of the mononuclear phagocyte system, particularly splenic macrophages. The premature death and lysis of RBC result in mild-to-severe nonspherocytic hemolytic anemia, with the severe form requiring regular transfusions. Among patients with rare genetic defects of glycolytic enzymes, the majority has a deficiency in PK. [Note: Liver PK is encoded by the same gene as the RBC
Biochemistry_Lippincott_353
Biochemistry_Lippinco
severe form requiring regular transfusions. Among patients with rare genetic defects of glycolytic enzymes, the majority has a deficiency in PK. [Note: Liver PK is encoded by the same gene as the RBC isozyme. However, liver cells show no effect because they can synthesize more PK and can also generate ATP by oxidative phosphorylation.] Severity depends both on the degree of enzyme deficiency (generally 5%–35% of normal levels) and on the extent to which RBC compensate by synthesizing increased levels of 2,3-BPG (see p. 31). Almost all individuals with PK deficiency have a mutant enzyme that shows altered kinetics or decreased stability (Fig. 8.20). Individuals heterozygous for PK deficiency have resistance to the most severe forms of malaria.
Biochemistry_Lippinco. severe form requiring regular transfusions. Among patients with rare genetic defects of glycolytic enzymes, the majority has a deficiency in PK. [Note: Liver PK is encoded by the same gene as the RBC isozyme. However, liver cells show no effect because they can synthesize more PK and can also generate ATP by oxidative phosphorylation.] Severity depends both on the degree of enzyme deficiency (generally 5%–35% of normal levels) and on the extent to which RBC compensate by synthesizing increased levels of 2,3-BPG (see p. 31). Almost all individuals with PK deficiency have a mutant enzyme that shows altered kinetics or decreased stability (Fig. 8.20). Individuals heterozygous for PK deficiency have resistance to the most severe forms of malaria.
Biochemistry_Lippincott_354
Biochemistry_Lippinco
The tissue-specific expression of PK in RBC and the liver results from the use of different start sites in transcription (see p. 473) of the gene that encodes the enzyme. K. Pyruvate reduction to lactate Lactate, formed from pyruvate by LDH, is the final product of anaerobic glycolysis in eukaryotic cells (Fig. 8.21). Reduction to lactate is the major fate for pyruvate in tissues that are poorly vascularized (for example, the lens and cornea of the eye and the kidney medulla) or in RBC that lack mitochondria. 1.
Biochemistry_Lippinco. The tissue-specific expression of PK in RBC and the liver results from the use of different start sites in transcription (see p. 473) of the gene that encodes the enzyme. K. Pyruvate reduction to lactate Lactate, formed from pyruvate by LDH, is the final product of anaerobic glycolysis in eukaryotic cells (Fig. 8.21). Reduction to lactate is the major fate for pyruvate in tissues that are poorly vascularized (for example, the lens and cornea of the eye and the kidney medulla) or in RBC that lack mitochondria. 1.
Biochemistry_Lippincott_355
Biochemistry_Lippinco
1. Lactate formation in muscle: In exercising skeletal muscle, NADH production (by glyceraldehyde 3-phosphate dehydrogenase and by the three NAD+-linked dehydrogenases of the TCA cycle, see p. 113) exceeds the oxidative capacity of the ETC. This results in an elevated NADH/NAD+ ratio, favoring reduction of pyruvate to lactate by LDH. Therefore, during intense exercise, lactate accumulates in muscle, causing a drop in the intracellular pH, potentially resulting in cramps. Much of this lactate eventually diffuses into the bloodstream and can be used by the liver to make glucose (see p. 118). 2.
Biochemistry_Lippinco. 1. Lactate formation in muscle: In exercising skeletal muscle, NADH production (by glyceraldehyde 3-phosphate dehydrogenase and by the three NAD+-linked dehydrogenases of the TCA cycle, see p. 113) exceeds the oxidative capacity of the ETC. This results in an elevated NADH/NAD+ ratio, favoring reduction of pyruvate to lactate by LDH. Therefore, during intense exercise, lactate accumulates in muscle, causing a drop in the intracellular pH, potentially resulting in cramps. Much of this lactate eventually diffuses into the bloodstream and can be used by the liver to make glucose (see p. 118). 2.
Biochemistry_Lippincott_356
Biochemistry_Lippinco
2. Lactate utilization: The direction of the LDH reaction depends on the relative intracellular concentrations of pyruvate and lactate and on the ratio of NADH/NAD+. For example, in the liver and heart, this ratio is lower than in exercising muscle. Consequently, the liver and heart oxidize lactate (obtained from the blood) to pyruvate. In the liver, pyruvate is either converted to glucose by gluconeogenesis or converted to acetyl CoA that is oxidized in the TCA cycle. Heart muscle exclusively oxidizes lactate to carbon dioxide and water via the TCA cycle. 3.
Biochemistry_Lippinco. 2. Lactate utilization: The direction of the LDH reaction depends on the relative intracellular concentrations of pyruvate and lactate and on the ratio of NADH/NAD+. For example, in the liver and heart, this ratio is lower than in exercising muscle. Consequently, the liver and heart oxidize lactate (obtained from the blood) to pyruvate. In the liver, pyruvate is either converted to glucose by gluconeogenesis or converted to acetyl CoA that is oxidized in the TCA cycle. Heart muscle exclusively oxidizes lactate to carbon dioxide and water via the TCA cycle. 3.
Biochemistry_Lippincott_357
Biochemistry_Lippinco
Lactic acidosis: Elevated concentrations of lactate in the plasma, termed lactic acidosis (a type of metabolic acidosis), occur when there is a collapse of the circulatory system, such as with myocardial infarction, pulmonary embolism, and uncontrolled hemorrhage, or when an individual is in shock. The failure to bring adequate amounts of O2 to the tissues results in impaired oxidative phosphorylation and decreased ATP synthesis. To survive, the cells rely on anaerobic glycolysis for generating ATP, producing lactic acid as the end product. [Note: Production of even meager amounts of ATP may be lifesaving during the period required to reestablish adequate blood flow to the tissues.] The additional O2 required to recover from a period when O2 availability has been inadequate is termed the O2 debt. [Note: The O2 debt is often related to patient morbidity or mortality. In many clinical situations, measuring the blood levels of lactic acid allows the rapid, early detection of O2 debt in
Biochemistry_Lippinco. Lactic acidosis: Elevated concentrations of lactate in the plasma, termed lactic acidosis (a type of metabolic acidosis), occur when there is a collapse of the circulatory system, such as with myocardial infarction, pulmonary embolism, and uncontrolled hemorrhage, or when an individual is in shock. The failure to bring adequate amounts of O2 to the tissues results in impaired oxidative phosphorylation and decreased ATP synthesis. To survive, the cells rely on anaerobic glycolysis for generating ATP, producing lactic acid as the end product. [Note: Production of even meager amounts of ATP may be lifesaving during the period required to reestablish adequate blood flow to the tissues.] The additional O2 required to recover from a period when O2 availability has been inadequate is termed the O2 debt. [Note: The O2 debt is often related to patient morbidity or mortality. In many clinical situations, measuring the blood levels of lactic acid allows the rapid, early detection of O2 debt in
Biochemistry_Lippincott_358
Biochemistry_Lippinco
O2 debt. [Note: The O2 debt is often related to patient morbidity or mortality. In many clinical situations, measuring the blood levels of lactic acid allows the rapid, early detection of O2 debt in patients and the monitoring of their recovery.]
Biochemistry_Lippinco. O2 debt. [Note: The O2 debt is often related to patient morbidity or mortality. In many clinical situations, measuring the blood levels of lactic acid allows the rapid, early detection of O2 debt in patients and the monitoring of their recovery.]
Biochemistry_Lippincott_359
Biochemistry_Lippinco
L. Energy yield from glycolysis Despite the production of some ATP by substrate-level phosphorylation during glycolysis, the end product, pyruvate or lactate, still contains most of the energy originally contained in glucose. The TCA cycle is required to release that energy completely (see p. 109). 1. Anaerobic glycolysis: A net of two molecules of ATP are generated for each molecule of glucose converted to two molecules of lactate (Fig. 8.22). There is no net production or consumption of NADH. 2. Aerobic glycolysis: The generation of ATP is the same as in anaerobic glycolysis (that is, a net gain of two ATP per molecule of glucose). Two molecules of NADH are also produced per molecule of glucose. Ongoing aerobic glycolysis requires the oxidation of most of this NADH by the ETC, producing three ATP for each NADH molecule entering the chain (see p. 77). [Note: NADH cannot cross the inner mitochondrial membrane, and substrate shuttles are required (see p. 79).]
Biochemistry_Lippinco. L. Energy yield from glycolysis Despite the production of some ATP by substrate-level phosphorylation during glycolysis, the end product, pyruvate or lactate, still contains most of the energy originally contained in glucose. The TCA cycle is required to release that energy completely (see p. 109). 1. Anaerobic glycolysis: A net of two molecules of ATP are generated for each molecule of glucose converted to two molecules of lactate (Fig. 8.22). There is no net production or consumption of NADH. 2. Aerobic glycolysis: The generation of ATP is the same as in anaerobic glycolysis (that is, a net gain of two ATP per molecule of glucose). Two molecules of NADH are also produced per molecule of glucose. Ongoing aerobic glycolysis requires the oxidation of most of this NADH by the ETC, producing three ATP for each NADH molecule entering the chain (see p. 77). [Note: NADH cannot cross the inner mitochondrial membrane, and substrate shuttles are required (see p. 79).]
Biochemistry_Lippincott_360
Biochemistry_Lippinco
VI. HORMONAL REGULATION
Biochemistry_Lippinco. VI. HORMONAL REGULATION
Biochemistry_Lippincott_361
Biochemistry_Lippinco
Regulation of the activity of the irreversible glycolytic enzymes by allosteric activation/inhibition or covalent phosphorylation/dephosphorylation is short term (that is, the effects occur over minutes or hours). Superimposed on these effects on the activity of preexisting enzyme molecules are the long-term hormonal effects on the number of new enzyme molecules. These hormonal effects can result in 10-to 20-fold increases in enzyme synthesis that typically occur over hours to days. Regular consumption of meals rich in carbohydrate or administration of insulin initiates an increase in the amount of glucokinase, PFK-1, and PK in the liver (Fig. 8.23). The change reflects an increase in gene transcription, resulting in increased enzyme synthesis. Increased availability of these three enzymes favors the conversion of glucose to pyruvate, a characteristic of the absorptive state (see p. 321). [Note: The transcriptional effects of insulin and carbohydrate (specifically glucose) are
Biochemistry_Lippinco. Regulation of the activity of the irreversible glycolytic enzymes by allosteric activation/inhibition or covalent phosphorylation/dephosphorylation is short term (that is, the effects occur over minutes or hours). Superimposed on these effects on the activity of preexisting enzyme molecules are the long-term hormonal effects on the number of new enzyme molecules. These hormonal effects can result in 10-to 20-fold increases in enzyme synthesis that typically occur over hours to days. Regular consumption of meals rich in carbohydrate or administration of insulin initiates an increase in the amount of glucokinase, PFK-1, and PK in the liver (Fig. 8.23). The change reflects an increase in gene transcription, resulting in increased enzyme synthesis. Increased availability of these three enzymes favors the conversion of glucose to pyruvate, a characteristic of the absorptive state (see p. 321). [Note: The transcriptional effects of insulin and carbohydrate (specifically glucose) are
Biochemistry_Lippincott_362
Biochemistry_Lippinco
enzymes favors the conversion of glucose to pyruvate, a characteristic of the absorptive state (see p. 321). [Note: The transcriptional effects of insulin and carbohydrate (specifically glucose) are mediated by the transcription factors sterol regulatory element–binding protein-1c and carbohydrate response element–binding protein, respectively. These factors also regulate transcription of genes involved in fatty acid synthesis (see p. 184).] Conversely, gene expression of the three enzymes is decreased when plasma glucagon is high and insulin is low (for example, as seen in fasting or diabetes).
Biochemistry_Lippinco. enzymes favors the conversion of glucose to pyruvate, a characteristic of the absorptive state (see p. 321). [Note: The transcriptional effects of insulin and carbohydrate (specifically glucose) are mediated by the transcription factors sterol regulatory element–binding protein-1c and carbohydrate response element–binding protein, respectively. These factors also regulate transcription of genes involved in fatty acid synthesis (see p. 184).] Conversely, gene expression of the three enzymes is decreased when plasma glucagon is high and insulin is low (for example, as seen in fasting or diabetes).
Biochemistry_Lippincott_363
Biochemistry_Lippinco
VII. ALTERNATE FATES OF PYRUVATE Pyruvate can be metabolized to products other than lactate. A. Oxidative decarboxylation to acetyl CoA Oxidative decarboxylation of pyruvate by the PDHC is an important pathway in tissues with a high oxidative capacity such as cardiac muscle (Fig. 8.24). PDHC irreversibly converts pyruvate, the end product of aerobic glycolysis, into acetyl CoA, a TCA cycle substrate (see p. 109) and the carbon source for fatty acid synthesis (see p. 183). B. Carboxylation to oxaloacetate Carboxylation of pyruvate to oxaloacetate by pyruvate carboxylase is a biotin-dependent reaction (see Fig. 8.24). This irreversible reaction is important because it replenishes the TCA cycle intermediate and provides substrate for gluconeogenesis (see p. 118). C. Reduction to ethanol (microorganisms)
Biochemistry_Lippinco. VII. ALTERNATE FATES OF PYRUVATE Pyruvate can be metabolized to products other than lactate. A. Oxidative decarboxylation to acetyl CoA Oxidative decarboxylation of pyruvate by the PDHC is an important pathway in tissues with a high oxidative capacity such as cardiac muscle (Fig. 8.24). PDHC irreversibly converts pyruvate, the end product of aerobic glycolysis, into acetyl CoA, a TCA cycle substrate (see p. 109) and the carbon source for fatty acid synthesis (see p. 183). B. Carboxylation to oxaloacetate Carboxylation of pyruvate to oxaloacetate by pyruvate carboxylase is a biotin-dependent reaction (see Fig. 8.24). This irreversible reaction is important because it replenishes the TCA cycle intermediate and provides substrate for gluconeogenesis (see p. 118). C. Reduction to ethanol (microorganisms)
Biochemistry_Lippincott_364
Biochemistry_Lippinco
C. Reduction to ethanol (microorganisms) The reduction of pyruvate to ethanol occurs by the two reactions summarized in Figure 8.24. The decarboxylation of pyruvate to acetaldehyde by thiamine-requiring pyruvate decarboxylase occurs in yeast and certain other microorganisms but not in humans. VIII. CHAPTER SUMMARY
Biochemistry_Lippinco. C. Reduction to ethanol (microorganisms) The reduction of pyruvate to ethanol occurs by the two reactions summarized in Figure 8.24. The decarboxylation of pyruvate to acetaldehyde by thiamine-requiring pyruvate decarboxylase occurs in yeast and certain other microorganisms but not in humans. VIII. CHAPTER SUMMARY
Biochemistry_Lippincott_365
Biochemistry_Lippinco
Most pathways can be classified as either catabolic (degrade complex molecules to a few simple products with ATP production) or anabolic (synthesize complex end products from simple precursors with ATP hydrolysis). The rate of a metabolic pathway can respond to regulatory signals such as intracellular allosteric activators or inhibitors. Intercellular signaling provides for the integration of metabolism. The primary route of this communication is chemical signaling (for example, by hormones or neurotransmitters). Second messenger molecules transduce a chemical signal (hormone or neurotransmitter binding) to appropriate intracellular responders. Adenylyl cyclase (AC) is a cell membrane enzyme that synthesizes cyclic adenosine monophosphate (cAMP) in response to chemical signals, such as the hormones glucagon and epinephrine. Following binding of a hormone to its cell-surface G protein–coupled receptor, a guanosine triphosphate–dependent regulatory protein (G protein) is activated that,
Biochemistry_Lippinco. Most pathways can be classified as either catabolic (degrade complex molecules to a few simple products with ATP production) or anabolic (synthesize complex end products from simple precursors with ATP hydrolysis). The rate of a metabolic pathway can respond to regulatory signals such as intracellular allosteric activators or inhibitors. Intercellular signaling provides for the integration of metabolism. The primary route of this communication is chemical signaling (for example, by hormones or neurotransmitters). Second messenger molecules transduce a chemical signal (hormone or neurotransmitter binding) to appropriate intracellular responders. Adenylyl cyclase (AC) is a cell membrane enzyme that synthesizes cyclic adenosine monophosphate (cAMP) in response to chemical signals, such as the hormones glucagon and epinephrine. Following binding of a hormone to its cell-surface G protein–coupled receptor, a guanosine triphosphate–dependent regulatory protein (G protein) is activated that,
Biochemistry_Lippincott_366
Biochemistry_Lippinco
hormones glucagon and epinephrine. Following binding of a hormone to its cell-surface G protein–coupled receptor, a guanosine triphosphate–dependent regulatory protein (G protein) is activated that, in turn, activates AC. The cAMP produced activates protein kinase A, which phosphorylates a variety of enzymes, causing their activation or deactivation. Phosphorylation is reversed by phosphatases. Aerobic glycolysis, in which pyruvate is the end product, occurs in cells with mitochondria and an adequate supply of oxygen ([O2],
Biochemistry_Lippinco. hormones glucagon and epinephrine. Following binding of a hormone to its cell-surface G protein–coupled receptor, a guanosine triphosphate–dependent regulatory protein (G protein) is activated that, in turn, activates AC. The cAMP produced activates protein kinase A, which phosphorylates a variety of enzymes, causing their activation or deactivation. Phosphorylation is reversed by phosphatases. Aerobic glycolysis, in which pyruvate is the end product, occurs in cells with mitochondria and an adequate supply of oxygen ([O2],
Biochemistry_Lippincott_367
Biochemistry_Lippinco
Fig. 8.25). Anaerobic glycolysis, in which lactic acid is the end product, occurs in cells that lack mitochondria and in cells deprived of sufficient O2. Glucose is passively transported across membranes by 1 of 14 glucose transporter (GLUT) isoforms. GLUT-1 is abundant in RBC and the brain, GLUT-4 (which is insulin dependent) in muscle and adipose tissue, and GLUT-2 in the liver, kidneys, and pancreatic β cells. The oxidation of glucose to pyruvate (glycolysis, see Fig. 8.25) occurs through an energy-investment phase in which phosphorylated intermediates are synthesized at the expense of ATP and an energy-generation phase in which ATP is produced by substrate-level phosphorylation. In the energy-investment phase, glucose is phosphorylated by hexokinase (found in most tissues) or glucokinase (a hexokinase found in liver cells and pancreatic β cells). Hexokinase has a high affinity (low Km) and a low maximal velocity (Vmax) for glucose and is inhibited by glucose 6-phosphate.
Biochemistry_Lippinco. Fig. 8.25). Anaerobic glycolysis, in which lactic acid is the end product, occurs in cells that lack mitochondria and in cells deprived of sufficient O2. Glucose is passively transported across membranes by 1 of 14 glucose transporter (GLUT) isoforms. GLUT-1 is abundant in RBC and the brain, GLUT-4 (which is insulin dependent) in muscle and adipose tissue, and GLUT-2 in the liver, kidneys, and pancreatic β cells. The oxidation of glucose to pyruvate (glycolysis, see Fig. 8.25) occurs through an energy-investment phase in which phosphorylated intermediates are synthesized at the expense of ATP and an energy-generation phase in which ATP is produced by substrate-level phosphorylation. In the energy-investment phase, glucose is phosphorylated by hexokinase (found in most tissues) or glucokinase (a hexokinase found in liver cells and pancreatic β cells). Hexokinase has a high affinity (low Km) and a low maximal velocity (Vmax) for glucose and is inhibited by glucose 6-phosphate.
Biochemistry_Lippincott_368
Biochemistry_Lippinco
glucokinase (a hexokinase found in liver cells and pancreatic β cells). Hexokinase has a high affinity (low Km) and a low maximal velocity (Vmax) for glucose and is inhibited by glucose 6-phosphate. Glucokinase has a high Km and a high Vmax for glucose. It is regulated indirectly by fructose 6-phosphate (inhibits) and glucose (activates) via glucokinase regulatory protein. Glucose 6-phosphate is isomerized to fructose 6phosphate, which is phosphorylated to fructose 1,6-bisphosphate by phosphofructokinase-1 (PFK-1). This enzyme is allosterically inhibited by ATP and citrate and activated by AMP. Fructose 2,6-bisphosphate, whose synthesis by bifunctional phosphofructokinase-2 (PFK-2) is increased in the liver by insulin and decreased by glucagon, is the most potent allosteric activator of PFK-1. A total of two ATP are used during this phase of glycolysis. Fructose 1,6-bisphosphate is cleaved to form two trioses that are further metabolized by the glycolytic pathway, forming pyruvate.
Biochemistry_Lippinco. glucokinase (a hexokinase found in liver cells and pancreatic β cells). Hexokinase has a high affinity (low Km) and a low maximal velocity (Vmax) for glucose and is inhibited by glucose 6-phosphate. Glucokinase has a high Km and a high Vmax for glucose. It is regulated indirectly by fructose 6-phosphate (inhibits) and glucose (activates) via glucokinase regulatory protein. Glucose 6-phosphate is isomerized to fructose 6phosphate, which is phosphorylated to fructose 1,6-bisphosphate by phosphofructokinase-1 (PFK-1). This enzyme is allosterically inhibited by ATP and citrate and activated by AMP. Fructose 2,6-bisphosphate, whose synthesis by bifunctional phosphofructokinase-2 (PFK-2) is increased in the liver by insulin and decreased by glucagon, is the most potent allosteric activator of PFK-1. A total of two ATP are used during this phase of glycolysis. Fructose 1,6-bisphosphate is cleaved to form two trioses that are further metabolized by the glycolytic pathway, forming pyruvate.
Biochemistry_Lippincott_369
Biochemistry_Lippinco
PFK-1. A total of two ATP are used during this phase of glycolysis. Fructose 1,6-bisphosphate is cleaved to form two trioses that are further metabolized by the glycolytic pathway, forming pyruvate. During this phase, four ATP and two nicotinamide adenine dinucleotide (NADH) are produced per glucose molecule. The final step in pyruvate synthesis from phosphoenolpyruvate is catalyzed by pyruvate kinase (PK). This enzyme is allosterically activated by fructose 1,6-bisphosphate, and the hepatic isozyme is inhibited covalently by glucagon via the cAMP pathway. PK deficiency accounts for the majority of all inherited defects in glycolytic enzymes. Effects are restricted to RBC and present as mild-tosevere chronic, nonspherocytic hemolytic anemia. Glycolytic gene transcription is enhanced by insulin and glucose. In anaerobic glycolysis, NADH is reoxidized to NAD+ by the reduction of pyruvate to lactate via lactate dehydrogenase. This occurs in cells such as RBC that lack mitochondria and in
Biochemistry_Lippinco. PFK-1. A total of two ATP are used during this phase of glycolysis. Fructose 1,6-bisphosphate is cleaved to form two trioses that are further metabolized by the glycolytic pathway, forming pyruvate. During this phase, four ATP and two nicotinamide adenine dinucleotide (NADH) are produced per glucose molecule. The final step in pyruvate synthesis from phosphoenolpyruvate is catalyzed by pyruvate kinase (PK). This enzyme is allosterically activated by fructose 1,6-bisphosphate, and the hepatic isozyme is inhibited covalently by glucagon via the cAMP pathway. PK deficiency accounts for the majority of all inherited defects in glycolytic enzymes. Effects are restricted to RBC and present as mild-tosevere chronic, nonspherocytic hemolytic anemia. Glycolytic gene transcription is enhanced by insulin and glucose. In anaerobic glycolysis, NADH is reoxidized to NAD+ by the reduction of pyruvate to lactate via lactate dehydrogenase. This occurs in cells such as RBC that lack mitochondria and in
Biochemistry_Lippincott_370
Biochemistry_Lippinco
and glucose. In anaerobic glycolysis, NADH is reoxidized to NAD+ by the reduction of pyruvate to lactate via lactate dehydrogenase. This occurs in cells such as RBC that lack mitochondria and in tissues such as exercising muscle, where production of NADH exceeds the oxidative capacity of the respiratory chain. Elevated concentrations of lactate in the plasma (lactic acidosis) occur with circulatory system collapse or shock. Pyruvate also can be 1) oxidatively decarboxylated to acetyl CoA by pyruvate dehydrogenase, 2) carboxylated to oxaloacetate (a TCA cycle intermediate) by pyruvate carboxylase, or 3) reduced to ethanol by microbial pyruvate decarboxylase.
Biochemistry_Lippinco. and glucose. In anaerobic glycolysis, NADH is reoxidized to NAD+ by the reduction of pyruvate to lactate via lactate dehydrogenase. This occurs in cells such as RBC that lack mitochondria and in tissues such as exercising muscle, where production of NADH exceeds the oxidative capacity of the respiratory chain. Elevated concentrations of lactate in the plasma (lactic acidosis) occur with circulatory system collapse or shock. Pyruvate also can be 1) oxidatively decarboxylated to acetyl CoA by pyruvate dehydrogenase, 2) carboxylated to oxaloacetate (a TCA cycle intermediate) by pyruvate carboxylase, or 3) reduced to ethanol by microbial pyruvate decarboxylase.
Biochemistry_Lippincott_371
Biochemistry_Lippinco
Choose the ONE best answer. .1. Which of the following best describes the activity level and phosphorylation state of the listed hepatic enzymes in an individual who consumed a carbohydrate-rich meal about an hour ago? PFK-1 = phosphofructokinase1; PFK-2 = phosphofructokinase-2; P = phosphorylated. Correct answer = C. Immediately following a meal, blood glucose levels and hepatic uptake of glucose increase. The glucose is phosphorylated to glucose 6-phosphate and used in glycolysis. In response to the rise in blood glucose, the insulin/glucagon ratio increases. As a result, the kinase domain of PFK-2 is dephosphorylated and active. Its product, fructose 2,6-bisphosphate, allosterically activates PFK-1. (PFK-1 is not covalently regulated.) Active PFK-1 produces fructose 1,6-bisphosphate that is a feedforward activator of pyruvate kinase. Hepatic pyruvate kinase is covalently regulated, and the rise in insulin favors dephosphorylation and activation.
Biochemistry_Lippinco. Choose the ONE best answer. .1. Which of the following best describes the activity level and phosphorylation state of the listed hepatic enzymes in an individual who consumed a carbohydrate-rich meal about an hour ago? PFK-1 = phosphofructokinase1; PFK-2 = phosphofructokinase-2; P = phosphorylated. Correct answer = C. Immediately following a meal, blood glucose levels and hepatic uptake of glucose increase. The glucose is phosphorylated to glucose 6-phosphate and used in glycolysis. In response to the rise in blood glucose, the insulin/glucagon ratio increases. As a result, the kinase domain of PFK-2 is dephosphorylated and active. Its product, fructose 2,6-bisphosphate, allosterically activates PFK-1. (PFK-1 is not covalently regulated.) Active PFK-1 produces fructose 1,6-bisphosphate that is a feedforward activator of pyruvate kinase. Hepatic pyruvate kinase is covalently regulated, and the rise in insulin favors dephosphorylation and activation.
Biochemistry_Lippincott_372
Biochemistry_Lippinco
.2. Which of the following statements is true for anabolic pathways only? A. Their irreversible (nonequilibrium) reactions are regulated. B. They are called cycles if they regenerate an intermediate. C. They are convergent and generate a few simple products. D. They are synthetic and require energy. E. They typically require oxidized coenzymes. Correct answer = D. Anabolic processes are synthetic and energy requiring (endergonic). Statements A and B apply to both anabolic and catabolic processes, whereas C and E apply only to catabolic processes. .3. Compared with the resting state, vigorously contracting skeletal muscle shows: A. decreased AMP/ATP ratio. B. decreased levels of fructose 2,6-bisphosphate. C. decreased NADH/NAD+ ratio. D. increased oxygen availability. E. increased reduction of pyruvate to lactate.
Biochemistry_Lippinco. .2. Which of the following statements is true for anabolic pathways only? A. Their irreversible (nonequilibrium) reactions are regulated. B. They are called cycles if they regenerate an intermediate. C. They are convergent and generate a few simple products. D. They are synthetic and require energy. E. They typically require oxidized coenzymes. Correct answer = D. Anabolic processes are synthetic and energy requiring (endergonic). Statements A and B apply to both anabolic and catabolic processes, whereas C and E apply only to catabolic processes. .3. Compared with the resting state, vigorously contracting skeletal muscle shows: A. decreased AMP/ATP ratio. B. decreased levels of fructose 2,6-bisphosphate. C. decreased NADH/NAD+ ratio. D. increased oxygen availability. E. increased reduction of pyruvate to lactate.
Biochemistry_Lippincott_373
Biochemistry_Lippinco
A. decreased AMP/ATP ratio. B. decreased levels of fructose 2,6-bisphosphate. C. decreased NADH/NAD+ ratio. D. increased oxygen availability. E. increased reduction of pyruvate to lactate. Correct answer = E. Vigorously contracting skeletal muscle shows an increase in the reduction of pyruvate to lactate compared with resting muscle. The levels of reduced nicotinamide adenine dinucleotide (NADH) increase and exceed the oxidative capacity of the electron transport chain. Consequently, the levels of adenosine monophosphate (AMP) increase. The concentration of fructose 2,6-bisphosphate is not a key regulatory factor in skeletal muscle. .4. Glucose uptake by: A. brain cells is through energy-requiring (active) transport. B. intestinal mucosal cells requires insulin. C. liver cells is through facilitated diffusion involving a glucose transporter. D. most cells is through simple diffusion up a concentration gradient.
Biochemistry_Lippinco. A. decreased AMP/ATP ratio. B. decreased levels of fructose 2,6-bisphosphate. C. decreased NADH/NAD+ ratio. D. increased oxygen availability. E. increased reduction of pyruvate to lactate. Correct answer = E. Vigorously contracting skeletal muscle shows an increase in the reduction of pyruvate to lactate compared with resting muscle. The levels of reduced nicotinamide adenine dinucleotide (NADH) increase and exceed the oxidative capacity of the electron transport chain. Consequently, the levels of adenosine monophosphate (AMP) increase. The concentration of fructose 2,6-bisphosphate is not a key regulatory factor in skeletal muscle. .4. Glucose uptake by: A. brain cells is through energy-requiring (active) transport. B. intestinal mucosal cells requires insulin. C. liver cells is through facilitated diffusion involving a glucose transporter. D. most cells is through simple diffusion up a concentration gradient.
Biochemistry_Lippincott_374
Biochemistry_Lippinco
C. liver cells is through facilitated diffusion involving a glucose transporter. D. most cells is through simple diffusion up a concentration gradient. Correct answer = C. Glucose uptake in the liver, brain, muscle, and adipose tissue is down a concentration gradient, and the diffusion is facilitated by tissue-specific glucose transporters (GLUT). In adipose and muscle tissues, insulin is required for glucose uptake. Moving glucose against a concentration gradient requires energy and is seen with the sodium-dependent glucose cotransporter 1 (SGLT1) of intestinal mucosal cells. .5. Given that the Km of glucokinase for glucose is 10 mM, whereas that of hexokinase is 0.1 mM, which isozyme will more closely approach Vmax at the normal blood glucose concentration of 5 mM?
Biochemistry_Lippinco. C. liver cells is through facilitated diffusion involving a glucose transporter. D. most cells is through simple diffusion up a concentration gradient. Correct answer = C. Glucose uptake in the liver, brain, muscle, and adipose tissue is down a concentration gradient, and the diffusion is facilitated by tissue-specific glucose transporters (GLUT). In adipose and muscle tissues, insulin is required for glucose uptake. Moving glucose against a concentration gradient requires energy and is seen with the sodium-dependent glucose cotransporter 1 (SGLT1) of intestinal mucosal cells. .5. Given that the Km of glucokinase for glucose is 10 mM, whereas that of hexokinase is 0.1 mM, which isozyme will more closely approach Vmax at the normal blood glucose concentration of 5 mM?
Biochemistry_Lippincott_375
Biochemistry_Lippinco
.5. Given that the Km of glucokinase for glucose is 10 mM, whereas that of hexokinase is 0.1 mM, which isozyme will more closely approach Vmax at the normal blood glucose concentration of 5 mM? Correct answer = Hexokinase. Km (Michaelis constant) is that substrate concentration that gives one half Vmax (maximal velocity). When blood glucose concentration is 5 mM, hexokinase (Km = 0.1 mM) will be saturated, but glucokinase (Km = 10 mM) will not. .6. In patients with whooping cough, Gαi is inhibited. How does this lead to a rise in cyclic adenosine monophosphate (cAMP)? G proteins of the Gαi type inhibit adenylyl cyclase (AC) when their associated G protein–coupled receptor is bound by ligand. If Gαi is inhibited by pertussis toxin, AC production of cAMP is inappropriately activated. For additional ancillary materials related to this chapter, please visit thePoint. I. CYCLE OVERVIEW
Biochemistry_Lippinco. .5. Given that the Km of glucokinase for glucose is 10 mM, whereas that of hexokinase is 0.1 mM, which isozyme will more closely approach Vmax at the normal blood glucose concentration of 5 mM? Correct answer = Hexokinase. Km (Michaelis constant) is that substrate concentration that gives one half Vmax (maximal velocity). When blood glucose concentration is 5 mM, hexokinase (Km = 0.1 mM) will be saturated, but glucokinase (Km = 10 mM) will not. .6. In patients with whooping cough, Gαi is inhibited. How does this lead to a rise in cyclic adenosine monophosphate (cAMP)? G proteins of the Gαi type inhibit adenylyl cyclase (AC) when their associated G protein–coupled receptor is bound by ligand. If Gαi is inhibited by pertussis toxin, AC production of cAMP is inappropriately activated. For additional ancillary materials related to this chapter, please visit thePoint. I. CYCLE OVERVIEW
Biochemistry_Lippincott_376
Biochemistry_Lippinco
I. CYCLE OVERVIEW The tricarboxylic acid cycle ([TCA cycle] also called the citric acid cycle, or the Krebs cycle) plays several roles in metabolism. It is the final pathway where the oxidative catabolism of carbohydrates, amino acids, and fatty acids converge, their carbon skeletons being converted to carbon dioxide (CO2), as shown in cycle. The TCA cycle is an aerobic pathway, because oxygen (O2) is required as the final electron acceptor. Reactions such as the catabolism of some amino acids generate intermediates of the cycle and are called anaplerotic (from the Greek for “filling up”) reactions. The TCA cycle also provides intermediates for a number of important anabolic reactions, such as glucose formation from the carbon skeletons of some amino acids and the synthesis of some amino acids (see p. 267) and heme (see p. 278). Therefore, this cycle should not be viewed as a closed system but, instead, as an open one with compounds entering and leaving as required.
Biochemistry_Lippinco. I. CYCLE OVERVIEW The tricarboxylic acid cycle ([TCA cycle] also called the citric acid cycle, or the Krebs cycle) plays several roles in metabolism. It is the final pathway where the oxidative catabolism of carbohydrates, amino acids, and fatty acids converge, their carbon skeletons being converted to carbon dioxide (CO2), as shown in cycle. The TCA cycle is an aerobic pathway, because oxygen (O2) is required as the final electron acceptor. Reactions such as the catabolism of some amino acids generate intermediates of the cycle and are called anaplerotic (from the Greek for “filling up”) reactions. The TCA cycle also provides intermediates for a number of important anabolic reactions, such as glucose formation from the carbon skeletons of some amino acids and the synthesis of some amino acids (see p. 267) and heme (see p. 278). Therefore, this cycle should not be viewed as a closed system but, instead, as an open one with compounds entering and leaving as required.
Biochemistry_Lippincott_377
Biochemistry_Lippinco
II. CYCLE REACTIONS In the TCA cycle, oxaloacetate (OAA) is first condensed with an acetyl group from acetyl coenzyme A (CoA) and then is regenerated as the cycle is completed (see Fig. 9.1). Two carbons enter the cycle as acetyl CoA and two leave as CO2. Therefore, the entry of one acetyl CoA into one round of the TCA cycle does not lead to the net production or consumption of intermediates. A. Acetyl CoA production
Biochemistry_Lippinco. II. CYCLE REACTIONS In the TCA cycle, oxaloacetate (OAA) is first condensed with an acetyl group from acetyl coenzyme A (CoA) and then is regenerated as the cycle is completed (see Fig. 9.1). Two carbons enter the cycle as acetyl CoA and two leave as CO2. Therefore, the entry of one acetyl CoA into one round of the TCA cycle does not lead to the net production or consumption of intermediates. A. Acetyl CoA production
Biochemistry_Lippincott_378
Biochemistry_Lippinco
The major source of acetyl CoA for the TCA cycle is the oxidative decarboxylation of pyruvate by the multienzyme pyruvate dehydrogenase complex (PDH complex, or PDHC). However, the PDHC (described below) is not a component of the TCA cycle. Pyruvate, the end product of aerobic glycolysis, is transported from the cytosol into the mitochondrial matrix by the pyruvate mitochondrial carrier of the inner mitochondrial membrane. In the matrix, the PDHC converts pyruvate to acetyl CoA. [Note: Fatty acid oxidation is another source of acetyl CoA (see p. 192).] 1. PDHC component enzymes: The PDHC is a protein aggregate of multiple copies of three enzymes, pyruvate decarboxylase ([E1] sometimes called pyruvate dehydrogenase), dihydrolipoyl transacetylase (E2), and dihydrolipoyl dehydrogenase (E3). Each catalyzes a part of the overall reaction (Fig. 9.2). Their physical association links the reactions in proper sequence without the release of intermediates. In addition to the enzymes
Biochemistry_Lippinco. The major source of acetyl CoA for the TCA cycle is the oxidative decarboxylation of pyruvate by the multienzyme pyruvate dehydrogenase complex (PDH complex, or PDHC). However, the PDHC (described below) is not a component of the TCA cycle. Pyruvate, the end product of aerobic glycolysis, is transported from the cytosol into the mitochondrial matrix by the pyruvate mitochondrial carrier of the inner mitochondrial membrane. In the matrix, the PDHC converts pyruvate to acetyl CoA. [Note: Fatty acid oxidation is another source of acetyl CoA (see p. 192).] 1. PDHC component enzymes: The PDHC is a protein aggregate of multiple copies of three enzymes, pyruvate decarboxylase ([E1] sometimes called pyruvate dehydrogenase), dihydrolipoyl transacetylase (E2), and dihydrolipoyl dehydrogenase (E3). Each catalyzes a part of the overall reaction (Fig. 9.2). Their physical association links the reactions in proper sequence without the release of intermediates. In addition to the enzymes
Biochemistry_Lippincott_379
Biochemistry_Lippinco
(E3). Each catalyzes a part of the overall reaction (Fig. 9.2). Their physical association links the reactions in proper sequence without the release of intermediates. In addition to the enzymes participating in the conversion of pyruvate to acetyl CoA, the PDHC also contains two regulatory enzymes, pyruvate dehydrogenase kinase (PDH kinase) and pyruvate dehydrogenase phosphatase (PDH phosphatase).
Biochemistry_Lippinco. (E3). Each catalyzes a part of the overall reaction (Fig. 9.2). Their physical association links the reactions in proper sequence without the release of intermediates. In addition to the enzymes participating in the conversion of pyruvate to acetyl CoA, the PDHC also contains two regulatory enzymes, pyruvate dehydrogenase kinase (PDH kinase) and pyruvate dehydrogenase phosphatase (PDH phosphatase).
Biochemistry_Lippincott_380
Biochemistry_Lippinco
dioxide; TPP = thiamine pyrophosphate; L = lipoic acid; CoA = coenzyme A; FAD(H2) and NAD(H) = flavin and nicotinamide adenine dinucleotides; ~ = high-energy bond. 2. Coenzymes: The PDHC contains five coenzymes that act as carriers or oxidants for the intermediates of the reactions shown in Figure 9.2. E1 requires thiamine pyrophosphate (TPP), E2 requires lipoic acid and CoA, and E3 requires FAD and NAD+. [Note: TPP, lipoic acid, and FAD are tightly bound to the enzymes and function as coenzymes–prosthetic groups (see p. 54).] Deficiencies of thiamine or niacin can cause serious central nervous system problems. This is because brain cells are unable to produce sufficient ATP (via the TCA cycle) if the PDHC is inactive. Wernicke-Korsakoff, an encephalopathy-psychosis syndrome due to thiamine deficiency, may be seen with alcohol abuse (see p. 383).
Biochemistry_Lippinco. dioxide; TPP = thiamine pyrophosphate; L = lipoic acid; CoA = coenzyme A; FAD(H2) and NAD(H) = flavin and nicotinamide adenine dinucleotides; ~ = high-energy bond. 2. Coenzymes: The PDHC contains five coenzymes that act as carriers or oxidants for the intermediates of the reactions shown in Figure 9.2. E1 requires thiamine pyrophosphate (TPP), E2 requires lipoic acid and CoA, and E3 requires FAD and NAD+. [Note: TPP, lipoic acid, and FAD are tightly bound to the enzymes and function as coenzymes–prosthetic groups (see p. 54).] Deficiencies of thiamine or niacin can cause serious central nervous system problems. This is because brain cells are unable to produce sufficient ATP (via the TCA cycle) if the PDHC is inactive. Wernicke-Korsakoff, an encephalopathy-psychosis syndrome due to thiamine deficiency, may be seen with alcohol abuse (see p. 383).
Biochemistry_Lippincott_381
Biochemistry_Lippinco
3. Regulation: Covalent modifications by the two regulatory enzymes of the PDHC alternately activate and inactivate E1. PDH kinase phosphorylates and inactivates E1, whereas PDH phosphatase dephosphorylates and activates E1 (Fig. 9.3). The kinase itself is allosterically activated by ATP, acetyl CoA, and NADH. Therefore, in the presence of these high-energy products, the PDHC is turned off. [Note: It is actually the rise in the ATP/ADP (adenosine diphosphate), NADH/NAD+, or acetyl CoA/CoA ratios that affects enzymic activity.] Pyruvate is a potent inhibitor of PDH kinase. Therefore, if pyruvate concentrations are elevated, E1 will be maximally active. Calcium (Ca2+) is a strong activator of PDH phosphatase, stimulating E1 activity. This is particularly important in skeletal muscle, where Ca2+ release during contraction stimulates the PDHC and, thus, energy production. [Note: Although covalent regulation by the kinase and phosphatase is primary, the PDHC is also subject to product
Biochemistry_Lippinco. 3. Regulation: Covalent modifications by the two regulatory enzymes of the PDHC alternately activate and inactivate E1. PDH kinase phosphorylates and inactivates E1, whereas PDH phosphatase dephosphorylates and activates E1 (Fig. 9.3). The kinase itself is allosterically activated by ATP, acetyl CoA, and NADH. Therefore, in the presence of these high-energy products, the PDHC is turned off. [Note: It is actually the rise in the ATP/ADP (adenosine diphosphate), NADH/NAD+, or acetyl CoA/CoA ratios that affects enzymic activity.] Pyruvate is a potent inhibitor of PDH kinase. Therefore, if pyruvate concentrations are elevated, E1 will be maximally active. Calcium (Ca2+) is a strong activator of PDH phosphatase, stimulating E1 activity. This is particularly important in skeletal muscle, where Ca2+ release during contraction stimulates the PDHC and, thus, energy production. [Note: Although covalent regulation by the kinase and phosphatase is primary, the PDHC is also subject to product
Biochemistry_Lippincott_382
Biochemistry_Lippinco
Ca2+ release during contraction stimulates the PDHC and, thus, energy production. [Note: Although covalent regulation by the kinase and phosphatase is primary, the PDHC is also subject to product (NADH and acetyl CoA) inhibition.] 4. Deficiency: A deficiency of the α subunits of the tetrameric E1 component of the PDHC, although very rare, is the most common biochemical cause of congenital lactic acidosis. The deficiency results in a decreased ability to convert pyruvate to acetyl CoA, causing pyruvate to be shunted to lactate via lactate dehydrogenase (see p. 103). This creates particular problems for the brain, which relies on the TCA cycle for most of its energy and is particularly sensitive to acidosis. Symptoms are variable and include neurodegeneration, muscle spasticity, and, in the neonatal-onset form, early death. The gene for the α subunit is X linked, and because both males and females may be affected, the deficiency is classified as X-linked dominant. Although there is no
Biochemistry_Lippinco. Ca2+ release during contraction stimulates the PDHC and, thus, energy production. [Note: Although covalent regulation by the kinase and phosphatase is primary, the PDHC is also subject to product (NADH and acetyl CoA) inhibition.] 4. Deficiency: A deficiency of the α subunits of the tetrameric E1 component of the PDHC, although very rare, is the most common biochemical cause of congenital lactic acidosis. The deficiency results in a decreased ability to convert pyruvate to acetyl CoA, causing pyruvate to be shunted to lactate via lactate dehydrogenase (see p. 103). This creates particular problems for the brain, which relies on the TCA cycle for most of its energy and is particularly sensitive to acidosis. Symptoms are variable and include neurodegeneration, muscle spasticity, and, in the neonatal-onset form, early death. The gene for the α subunit is X linked, and because both males and females may be affected, the deficiency is classified as X-linked dominant. Although there is no